The DealFlow Report
Transcription
The DealFlow Report
N e ws , I n fo r m at i o n TUESDAY NOVEMBER 18, 2014 VOLUME III, NO. 38 a n d An a l y s i s o f S m a l l E q u i t y Fin a nc e Tick size pilot said to be too complicated Flaws may doom effort to boost IPO market in this edition by dan lonkevich The tick size pilot study developed by the national stock exchanges and published for public comment by the Securities and Exchange Commission Nov. 3 has already caused a controversy over a prohibition of trades closing on dark markets. It has also caused some observers to question whether the proposed study will be too complicated and flawed to succeed. The study is meant to test whether small cap stocks would see more liquidity and if there would be more initial public offerings if shares traded in larger increments or “tick” sizes. Some market observers trace a decline in the IPO market to the decimalization of stock prices in 2001. The move from fractional to decimal pricing of stocks reduced spreads and brokerage firm trading revenue. That made it less economical for securities firms to make markets in small cap stocks and publish research on smaller companies. In June, the SEC ordered the national stock exchanges to develop a study of larger tick sizes and the effect they would have on small caps’ trading and liquidity. Rich dad company reverse merges Legacy Education Alliance Inc., which runs a financial education brand based on the best-selling book “Rich Dad Poor Dad,” went public in a reverse merger. Legacy provides seminars, online courses, mentoring and data subscriptions to teach financial savvy through the Rich Dad brand. Rich Dad is based on the teachings of self-help author Robert Kiyosaki. Legacy has an agreement to use the brand until August 2018, according to a filing with the Securities and Exchange Commission. Legacy also has an agreement with Robbie Fowler, an English former soccer player, to use his likeness to market courses on real estate investment. It also has an agreement with Martin Roberts, a TV personality. page 7 The pilot, as written, involves three test groups and a control group each consisting of 400 securities. The first control group would be quoted in five-cent increments, although the stocks may trade at any increment currently permitted. The second test group would be quoted in five-cent increments and traded in five-cent increments. The second test group could also be traded at the midpoint between the national best bid and the national best offer. In the second test group, retail investor orders could be provided with price improvement that is at least half a cent better than the best protected bid and the best protected offer. In addition, the second test group would allow for negotiated trades in increments of less than five cents. The third test group would follow the same quoting and trading rules as test group two, subject to a trade-at prohibition. The trade-at provision would effectively prohibit quoting and trading of wider tick sizes on dark exchanges or pools unless there was significant price improve- tick size continued on page 4 > Khosla affiliates set to acquire KiOR by kelsey butler About two months after a director resigned and warned of a bankruptcy filing, biofuel producer KiOR Inc. (KIOR) has filed for Chapter 11 protection with plans to sell its equity through a reorganization plan. The Pasadena, Texas, company submitted its petition in the U.S. Bankruptcy Court for the District of Delaware in Wilmington on Nov. 9 to implement a restructuring agreement with a lender and shareholder group comprising affiliates of Silicon Valley venture capitalist Vinod Khosla. The company’s nonoperational Columbus, Miss., production facility, owned by a debtor subsidiary, is not included in the bankruptcy, the company said in a Nov. 9 statement. Judge Christopher S. Sontchi on Friday signed an interim order approving a $15 million debtor-in-possession financing from Khosla’s Pasadena Investments LLC. A final DIP hearing is set for Dec. 8. The funding will support KiOR through its restructuring process. Court papers filed Nov. 9 show that Khosla affiliates including Pasadena have agreed to serve as stalking-horse bidder for KiOR’s equity under a reorganization plan. The lead bid, which would be subject to higher and better offers for the debtor’s assets, also comes from first-lien lender KFT Trust and second-lien kior continued on page 6 > Complete index to the latest news page 2 close C a p print back < Index > cover search view 2 the DEALFLOW REPORT Tu e sday N ovember 18 2014 INDEX Editor-in-Chief Adam Steinhauer ([email protected]) MARKET UPDATE 01 Tick size pilot said to be too complicated. Managing Editor Meghan Leerskov ([email protected]) 01 Khosla affiliates set to acquire KiOR. Senior Editors Donna Horowitz ([email protected]) Dan Lonkevich ([email protected]) 07 Rich Dad brand conference company goes public in shell merger. Associate Editors Bill Meagher ([email protected]) Kirk O’Neil ([email protected]) 08 Dendreon unveils debt-for-equity swap. DEALFLOW Researchers Roger Dent ([email protected]) THomas Park ([email protected]) JAmes Summitt ( [email protected]) Eric Vermilya ([email protected]) 09 Biotechnology Value Fund leads $43.4M PIPE by GTx. 09 Welsh Carson invests in Revel Systems. 10 USA Compression gets ATM for up to $150M. 10 On Deck takes swing at NYSE listing. 14 Wall Street, 15th Floor New York, NY 10005 11 Intrepid Aviation flies toward IPO. T: (888) 667-3325 Outside U.S.: (212) 313-9251 11 Peak readies run at IPO. E: [email protected] The DealFlow Report® is published on Tuesday of every week, except the Tuesdays following New Year’s, Independence Day, the first week of August, Thanksgiving, and Christmas (47 issues). The DealFlow Report is a trademark of The Deal. Data is provided by PrivateRaise, a service of The Deal, unless otherwise noted. 12 Southcross Energy gets ATM for up to $75M. REGULATORY UPDATE 13 Crowdfunding portal Eureeca fined. All rights reserved. © 2014 The Deal. Printing more than one copy or photocopying multiple versions of this newsletter without a multiple copy license is illegal and strictly prohibited. The Deal actively monitors abuse of this policy. Violations can result in the termination of your subscription without refund or recourse and could subject you to civil and/or criminal penalties. For information on how to obtain multiple or group licenses, please contact The Deal’s Subscription Sales Department at the number or email address listed above. 13 Former DGSE CEO ordered to repay company after accounting scandal. DATES & DEADLINES 14 The DealFlow Report is a general-circulation publication. No data herein should be construed to be recommendations to purchase, retain, or sell securities, or to provide investment advice of the companies mentioned or advertised. No fees are accepted for publishing any editorial information. The Deal, its subsidiaries, and its employees may, from time to time, purchase, own, or sell securities or other investment products of the companies discussed or advertised in this publication. SMALL CAP EQUITY FINANCE ACTIVITY 15 ISSUER INDEX 34 For use by original recipient only. It is illegal to forward or otherwise distribute without permission. close print back < index > cover search view THE DEAL ECONOMY EVENT Predictions & PERSPECTIVES for 2015 December 4, 2014 ||||||||||||||| NASDAQ MARKETSITE, New York City WAT C H T H E L I V E V I D E O S T R E A M The Deal Economy Event is Fast Approaching! ||||||||||||||||| TDE EVENT UNDERWRITERS Don’t wait to reserve your space for our annual forecasting conference. Streaming live from the NASDAQ MarketSite, watch the deliberations of the most influential investors and senior dealmakers as they discuss the outlook for dealmaking in 2015. Featured Speakers: • Roger C. Altman, Founder and Executive Chairman, Evercore • Mark Frackt, CFO, BuzzFeed • Spencer Fleischer, President, FFL REGISTER HERE Featured Guest Speakers OFFICIAL BROADCAST PARTNER Roger C. Altman Mark Frackt Spencer Fleischer Evercore BuzzFeed FFL To learn how your organization can support and participate in this exclusive gathering, please contact Emily Newman at 212-321-5565 or by email at [email protected]. close print back < Index > cover search view 4 the DEALFLOW REPORT Tu e sday November 18 2014 MARKET UPDATE < tick size from page 1 ment. Under the trade-at prohibition, a trading center that was not quoting would be prevented from price matching protected quotations. A trading center that was quoting at a protected quotation would be permitted to execute the order. Currently, dark pools and exchanges that do not quote are permitted to step in front of a price quotation and offer a slightly higher or lower price, effectively preventing the protected quotation from closing. The trade-at prohibition was added to the study out of concern that unless lit exchanges were protected, more retail investor trading would migrate to dark pools. Small cap interests are worried that the trade-at prohibition adds unnecessary complication and could ultimately doom an important study that might otherwise help resuscitate the market for small cap stocks. The trade-at prohibition is effectively a preference for the lit markets over the dark markets, observers said. “The SEC has a predisposition for lit exchanges” because they’re more transparent than dark pools and exchanges, said Steven Glass, CEO of Zeno Consulting Group LLC, a consulting firm that advises asset owners on their trading processes. The SEC believes “there needs to be a significant value from trading on the dark exchanges to justify the lack of transparency,” he said. The commission has been examining the possibility of a trade-at rule since at least 2010, long before the Jumpstart Our Businesses Startups Act of 2012 made a tick size pilot a policy goal, Glass said. Canada and Australia have their own tradeat prohibitions and have seen the amount of trading on dark markets and pools decline sharply. “To the extent that exchanges that have seen some of their trading market drained by the dark markets and pools have lobbied for a trade-at rule, they have found a receptive audience at the SEC,” Glass said. “The idea of the tick size pilot appears also to be convenient way for the SEC to explore the usefulness of a tradeat rule.” For his part, Glass said a trade-at rule may be essential to maximizing transparency and close print preventing the widest spreads from migrating to the dark markets to hide. “If you simply widen tick sizes without a trade-at rule, you run the risk of pushing more trading to the dark markets,” he said. “I don’t think they would want to put in place a program that inadvertently pushes money into the dark market.” Nevertheless, Glass said the trade-at rule has increased the complexity of the pilot and may have unintended consequences of its own. He and other critics of the pilot study also say that its proposed duration of one year may be too short. “It’s gotten very complex and it’s only a year,” Glass said. “I wonder whether or not there’s going to be enough data to draw conclusions from.” In addition, the pilot will require a “non-trivial amount of effort by market makers” and they may not be willing to do it, he said. “There’s a cost-benefit analysis. You might get results that are skewed. In spirit, I like the idea of studying this. My concern is there are so many exceptions.” Glass’s assessment of the tick size pilot and trade-at rule is shared by Spencer Mindlin, an analyst at Aite Group LLC, a research and advisory firm focused on business, technology and regulatory issues and their impact on the financial services industry. Mindlin, who is based in Washington, said the trade-at prohibition deserves its own pilot study rather than to be a part of the tick size pilot. “If you take a step back to look at the impact of trade-at, it’s potentially very anti-competitive,” he said. “One of the beauties of the U.S. market is it’s competitive balance. You can trade anywhere on an exchange or a dark pool. By implementing trade-at, you’re hampering competitiveness. It’s a draconian approach.” While Mindlin allowed that a higher minimum tick size may facilitate more interest in small cap stocks, he said “I don’t buy the leap that it means more IPOs. Small cap companies still have little confidence in the market.” A higher minimum tick size won’t facilitate improved price discovery unless the typical quote spread of a particular stock is wider than the target minimum tick size, Mindlin said. “Advocates of the trade-at rule, however, purport that it will improve price discovery by back < Index > Aite Group's Spencer Mindlin pushing more volume into the lit markets, but I would say neither is likely to lead to significantly more IPOs,” he said. A tick size pilot without the trade-at rule still may be worth doing, Mindlin said. “If the goal is to stimulate trading in small cap stocks by increasing the market maker’s profits by increasing tick size increments, it shouldn’t matter whether or not the orders are executed in lit markets, dark pools or from some payment for order flow arrangement with a dealer,” he said. “The broker’s obligation of best execution can already be evaluated, since Regulation NMS requires all trades to be printed to the tape regardless of where they were executed. In fact, the ability to trade blocks of small cap stocks in alternative trading venues may increase given the larger minimum tick size, which should result in lower transaction costs.” For his part, David Weild, the founder and CEO of IssuWorks Inc., said the SEC is wise to experiment with the trade-at rule to see how it affects the market, but it would be better if it was separated from the tick size pilot. “These guys are all direct beneficiaries of the current system,” Weild said, referring to cover CONTINUED > search view 5 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 MARKET UPDATE < Previous both the exchanges who designed the pilot and the dark market critics. “All the exchanges are on the high-frequency-trading gravy train.” Weild, a former vice chairman of the Nasdaq Stock Market, has advocated for wider tick sizes. His research was included in a 2011 advisory committee report the Treasury Department on how to improve the IPO market. “The idea for the tick size pilot came from yours truly,” Weild said. “I don’t know why they don’t ask people who don’t have a dog in the fight to design it or at least have a seat at the table. It’s ridiculous that they let the exchanges do it.” Moreover, Weild said that the pilot’s experimentation with nickel tick sizes is insufficient and that it also should test a dime tick size. “I think it’s a good idea to look at everything,” he said. Jeffrey Solomon, CEO of investment bank Cowen & Co., also called the trade-at rule an unnecessary distraction. He served on the Equity Capital Formation Task Force that came up with the concept of a tick size pilot as part of the JOBS Act. The task force “didn’t ask for the trade-at rule,” Solomon said. He also noted that the trade-at group in the pilot was “laced with exceptions.” Solomon said he’s concerned that a pilot study with the trade-at provision “will crater under its own complexity.” “Opponents of the pilot will then be able to say, ‘See. We tried and it doesn’t work,’” he said. Moreover, the controversy over the trade-at rule may not be the worst problem with the tick size pilot study, according to Solomon. The one-year length of the study may be a bigger issue. “I’m deeply concerned about that,” he said. “Our comment letter will recommend a minimum of three years.” IssuWorks’ Weild said he originally called for a five-year pilot. Solomon said that a longer study would be preferable because the market will need time to develop the infrastructure to properly test the wider tick sizes. “Most of the trades done today are through algorithms, not even just by high-frequency close print traders,” he said. “If I go to a retail broker for a trade, they’ll immediately ask me if I want VWAP (volume weighted average price) pricing. Then they put the order into an algorithm. “All algorithmic trading models rely on first observing human behavior and then the machines learn to replicate it. “If we go to the market with wider ticks, where you can only trade at this price or that price or the midpoint, I fully expect for the first several months there will be limited algorithmic trading and there will be a big drop-off in volume. Then, after a few months of watching human behavior, they’ll be able to develop new algorithms. For three to six months, you’re going to have a lack of algorithmic involvement. “If the pilot is only a year, I am concerned that a quarter to half of the results are going to be skewed by this lack of algorithmic involvement. There will be a hew and cry about how illconceived the pilot is.” The costs of developing the algorithms may be prohibitively expensive if the return on investment is only over a year, Solomon said. Also, a longer study might be more likely to allow larger tick sizes to be observed in both up and down markets. James Angel, a professor of finance at Georgetown University, said that, ideally, the pilot would follow the market through a full economic cycle with a downturn and a recovery. A longer time frame is required to allow the market to re-build the infrastructure that used to support small cap stocks, he said. “The idea is if we bring back a wider tick, we’ll bring back the old ecosystem that supported small cap companies,” Angel said. “But it took time to kill the old ecosystem, and it will take time to rebuild it.” Meanwhile, many in the small-cap market are scratching their heads about what the pilot study is designed to accomplish. “It’s ridiculously complex,” said Jack Hogoboom, a partner and vice chairman of the life sciences practice at law firm Lowenstein Sandler LLP. “You almost have to be a back office expert to know what they’re talking about.” Hogoboom said the market’s complexity, more than tick size, may explain why the ecosystem for small cap stocks went away in the first place. “All the dark pools and dark markets didn’t exist in the glory days of the IPO market in the back < Index > IssuWorks’ CEO David Weild ‘80s and ‘90s,” he said. “They’re incredibly effective competitors. The problem is much more complicated than the tick size is too small. The whole market has changed.” Hogoboom also noted that the tick size pilot study, as it’s currently proposed, would include companies with market values of up to $5 billion. “I don’t think of a $5 billion market cap company as a small cap,” he said. “All the companies in the study are subject to an automated quotation system. I’m not sure it’s capturing what it’s intended to capture. I don’t really know if the study subject is the market everyone is concerned about. It doesn’t seem relevant to the problem at hand.” Hogoboom also questioned how the SEC will judge the success of larger tick sizes in increasing liquidity. “What are they going to be measuring? What are the criteria? The description I saw didn’t say anything about that.” Hogoboom said he’s unconvinced that smaller tick sizes are really responsible for the dearth of IPOs over the past 14 years. “There’s no proof that a penny tick size has caused the IPO market to shrink,” he said. “And haven’t we had an incredible year-and-a-half run of IPOs? Is there really a problem?” n cover search view 6 the DEALFLOW REPORT Tu e sday N ovember 18 2014 MARKET UPDATE < kior from page 1 lenders Khosla Ventures III LP and VNK Management LLC. KiOR spokeswoman Jennifer E. Mercer said Pasadena Investments would forgive $16 million in debt under the deal. Court papers show any remaining first-lien debt would be converted to exit financing, and second-lien debt could be converted to new equity or canceled. The Khosla group would assume all outstanding liabilities under the company’s leases and all postpetition accounts payable under the deal. The aggregate liabilities were unclear from court papers. Under proposed bidding procedures, interested parties would have until Dec. 15 to offer at least $17.14 million for substantially all of KiOR’s assets. If KiOR received more than one competing offer by the bid deadline, it would conduct an auction on Dec. 17, at which bids would have to increase in increments of at least $250,000. The stalking horse would be entitled to expense reimbursement if beat out at auction. The debtor proposed a Dec. 22 sale hearing in the event of a rival bidder winning, with such a cash deal closing by Jan. 15. If the stalking horse won, KiOR would look to confirm its plan by Feb. 12 and exit Chapter 11 by Feb. 27. KiOR has not filed the plan, but a term sheet shows third-lien lenders and shareholders would be wiped out, while general unsecured creditors would receive interests in a trust holding causes of action. Continuing trade creditors also would receive a 50% cash payment on the effective date, while unsecured creditors owed less than $5,000 would receive just the 50% payment. Pasadena’s DIP, meanwhile, would mature in six months and be priced at 7.5%. Mercer said the financing is new money. The debtor, which makes biofuel from organic waste products such as wood chips and nonfood crops, has been plagued by operational issues such as structural design bottlenecks and mechanical problems. It suspended operations at its biofuel production site in Columbus in January, and in August announced that absent additional financing it would not be able to meet its obligations past Sept. 30 and would be forced to file for bankruptcy. The alternative energy company since May close print has been evaluating strategic alternatives, including a sale, with advisers from Guggenheim Securities LLC, the investment banking and capital markets business of Guggenheim Partners LLC. KiOR’s facility, completed in April 2012, was designed to produce 13 million gallons of biofuel annually, but it produced less than 1 million gallons during 2013. KiOR warned in an Aug. 11 Securities and Exchange Commission filing that it “does not believe it can restart the Columbus facility on an economically viable basis at this time and therefore cannot be certain as to whether it will be able to successfully secure additional financing or the ultimate timing of such additional financing.” According to the Form 10-Q, the biofuel producer entered into a protective advance loan agreement with Khosla and his KFT Trust vehicle in July, which provided for up to $15 million in cash advances due Oct. 31 with 8% PIK interest. KiOR had drawn $6.9 million under that agreement as of July 31. KiOR said in the 10-Q that, if it received the full amount available under the loan agreement, it would be able to sustain its operations through Sept. 30. The Protective Advance agreement was intended to replace a $15 million cut in funding potential under an agreement to provide up to $25 million in senior secured promissory notes as long as the company met certain milestones. KiOR drew the full $10 million possible under that agreement. The notes are priced at 8% and mature on April 2, 2017, unless the noteholders want to be paid sooner. Another tranche of financing under a previous agreement with Khosla would have been available if KiOR raised at least $400 million in additional financing, an outcome the company dismissed as “unlikely to come in the near term.” In addition, before the filing KiOR was operating under a forbearance agreement related to a $69.4 million loan due Sept. 30 from the Mississippi Development Authority. The agency agreed to forbear through Oct. 31 on its no-interest loan after KiOR missed a $1.875 million semiannual payment that was due on June 30. Court papers show Khosla affiliates were owed $159 million as of the petition date, with affiliates of Alberta Investment Management Corp. owed roughly $77 million. Specifically, back < Index > venture capitalist Vinod Khosla KiOR has $16.27 million in first-lien debt, with the trust as agent; $95.7 million in 2013 secondlien notes, with Khosla Ventures III as agent; $10.4 million in 2014 second-lien notes, with the trust as agent; and $115 million in third-lien debt, with 1538731 Alberta Ltd. as agent. SEC filings show KiOR reported $58.27 million in assets and $261.31 million in liabilities as of June 30. By July 31, it had just $800,000 in cash and cash equivalents. During the quarter ended June 30, the company recorded a net loss of $24.44 million on revenue of $231,000. In the same quarter last year, KiOR lost $38.49 million on $239,000 in revenue. The company’s largest unsecured creditors listed in court papers include Wilmer Cutler Pickering Hale and Dorr LLP (owed $1.31 million), IntraLinks Holdings Inc. ($296,876), PricewaterhouseCoopers LLP ($147,901), Southern Ionics Inc. ($142,921) and Leidos Engineering LLC ($121,893). KiOR owes trade creditors a total of $3.3 million. KiOR is backed by Khosla, counts Bill Gates’ Gates Ventures LLC among its investors, and had former U.S. Secretary of State Condoleezza Rice on its board until December. KiOR shares, traded on the OTC Pink exchange, were down 62% the afternoon of Nov. 10 to 2.8 cents. Debtor counsel John H. Knight at Richards, Layton & Finger PA could not be reached for comment. Michael J. Merchant and Amanda R. Steele of Richards Layton and Edward Ripley and Mark Wege of King & Spalding LLP are also debtor counsel. n —Lisa Allen contributed to this report. cover search view 7 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 MARKET UPDATE Rich Dad brand conference company goes public Brand based on ‘Rich Dad Poor Dad’ book by Meghan Leerskov Legacy Education Alliance Inc. (PRCD), which runs a financial education brand based on the best-selling book “Rich Dad Poor Dad,” went public in a reverse merger with a shell company. Cape Coral, Fla.-based Legacy provides seminars, online courses, mentoring and data subscriptions to teach financial savvy through the Rich Dad brand. Rich Dad is based on the teachings of self-help author Robert Kiyosaki. Legacy has an agreement to use the brand until August 2018, according to a Nov. 10 filing with the Securities and Exchange Commission. Legacy also has an agreement with Robbie Fowler, an English former soccer player, to use his likeness to market training courses on real estate investment. That agreement expires next January. The company has a marketing agreement with Martin Roberts, a British television personality and author of “Making Money from Property,” as well. Legacy was formerly part of the financial education company Tigrent Inc., which was founded in 1992. Legacy has 202 full-time employees in the U.S., U.K. and Canada, plus contracted coaches. The company’s financials improved in the first half of the year, after it settled a lawsuit against Rich Dad Operating Co. LLC, which leases the Rich Dad brand to Legacy. The lawsuit had claimed that Kiyosaki and others were promoting a series of live seminars and related products, known as “Rich Dad:GEO,” that infringed on Legacy’s exclusive license agreement. Under the settlement reached in April, Rich Dad Operating agreed to halve the royalty payable by Legacy to 2.5% for 2014, canceled about close print $1.3 million in debt Legacy owed, forfeited its right to appoint a member to the Legacy board and repaid Legacy’s legal fees. As a result, Legacy’s net income quadruped in the first half of the year to $7.77 million from $1.815 million in the first half of 2013. Legacy has several other lawsuits ongoing, according to its filing, including one in which it is trying to recoup $8.3 million in reserve funds in connection with credit card processing agreements. back < Index > Representatives of Legacy could not be reached for comment. Tigrent is still Legacy’s largest shareholder, with an 80% stake after the reverse merger. Andrew Glashow, founding partner of Scarsdale, N.Y.-based New World Merchant Partners LLC, owns 7.2%. Legacy CEO Anthony Humpage has been with the company since 2012. He was previously CFO of Rich Dad Operating. Humpage is a significant shareholder in Legacy, according to the merger filing. “We are pleased that we have been able to consummate this transaction,” he said in a Nov. 10 statement. “We look forward to leveraging this transaction to facilitate our future growth and development plans.” Chairman Murray Indick has been with the company since 2007. He is also senior counsel at the law firm Crowell & Moring LLP in San Francisco. Indick cofounded investment firm Prides Capital Partners LLC, which has held large stakes in Legacy through an affiliate, according to the filing. Shares of Legacy are still listed under the shell company Priced In Corp.’s ticker on the OTC Bulletin Board and OTCQB, but have not yet traded. The company has applied to change its symbol to LEAI. Priced In had planned to launch a website for group-buying deals, like Groupon Inc. (GRPN), but never became operational. In July, Jay Lasky, the owner of a Helly Hansen oceanwear store in Newport, R.I., paid $344,500 for a controlling stake in the shell. The law firm Herrick, Feinstein LLP in New York advised on the reverse merger. n cover search view 8 the DEALFLOW REPORT Tu e sday N ovember 18 2014 MARKET UPDATE Dendreon unveils debt-for-equity swap by jamie mason Dendreon Corp. (DNDN) filed for Chapter 11 on Nov. 10 with plans to cure its ailments through either a sale or a reorganization of the company. The Seattle biotechnology company and three affiliates submitted petitions in the U.S. Bankruptcy Court for the District of Delaware in Wilmington. Judge Peter J. Walsh Wednesday approved joint administration of Dendreon’s case with those of its affiliates, along with other firstday motions. Walsh is set to consider approval of the company’s plan support agreement and proposed bidding procedures at a Dec. 9 hearing. Dendreon, which focuses on cancer treatment, filed for bankruptcy protection after reaching an agreement on the terms of a restructuring with holders of 84% of its 2.875% convertible senior unsecured notes. The company owes $620 million on the notes, which come due Jan. 15, 2016. Bank of New York Mellon Trust Co. NA is the indenture trustee on the notes. Deerfield Management Co. LP is the largest noteholder, holding roughly 36% of the debt. Under the plan support agreement, the company will explore both a sale of its assets under Section 363 of the Bankruptcy Code and a recapitalization through a reorganization plan. Buyers can choose to either buy substantially all of the company’s assets or backstop a restructuring plan. Proposed bidding procedures call for qualified bidders to offer at least $275 million for the company’s assets. If looking to backstop a restructuring plan, interested parties also must provide at least $275 million. Dendreon doesn’t have a stalking-horse bidder in place but could name one by Dec. 29, according to the bidding procedures. If it did, the lead bidder would be entitled to up to a 3% breakup fee and up to $1 million in expense reimbursement if it lost at auction. Competing bidders would have until Jan. 27 to deposit 10% and top the stalking-horse bid by $1 million plus the amount of the breakup fee and expense reimbursement. If Dendreon received multiple offers, it would hold an auction by Feb. 3, at which bids would have to increase in increments of at least $250,000. close print Walsh would preside over a Feb. 10 sale hearing. If Dendreon received no qualified bids, it would convert the $620 million in notes into 100% of the equity in the reorganized company, court documents said. Administrative claims, priority tax claims and other priority claims would be repaid in full, along with any secured claims. General unsecured creditors likely would receive cash, and equity holders would be wiped out. “Whether the restructuring takes the form of a standalone recapitalization or a sale of the company or its assets, we are confident that this process will allow [Dendreon’s] Provenge to remain commercially available to the patients and providers who have come to rely on this revolutionary personalized cancer immunotherapy,” CEO W. Thomas Amick said in a statement Nov. 10. “We are pleased to have the support of a substantial majority of our senior noteholders through this restructuring and sale process.” The company said it had $100 million in cash as of Nov. 7, giving it sufficient liquidity to fund its stay in Chapter 11 without needing to raise any incremental financing. The company’s first commercialized cancer immunotherapy product, Provenge, was approved in 2010 by the Food and Drug Administration for the treatment of metastatic prostate cancer. There were high hopes for the drug, which went on the market in May 2010 and was expected to generate $4 billion in revenue by 2020, but the long and rocky road to approval, high cost of goods, fierce competition and a complex process to administer the therapy—which frustrated patients—combined to whittle those dreams down. Dendreon has cut costs significantly over the past few years, mostly by slashing personnel, starting with a 25% reduction in September 2011. In July 2012, it announced a restructuring to reduce its head count by 600 full-time and contractor positions. It also released plans to close its Morris Plains, N.J., manufacturing facility and make changes in its commercial operations. In its third-quarter 2013 financial report, Dendreon announced a layoff of 150 employees. It now has about one-third the number of employees it had at its peak, with roughly 700 employees. Last year, the company also embraced a new back < Index > account-based commercial model, focused on large account management and retained JPMorgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Inc. to assist it with exploring a sale, but ultimately Dendreon received no bids. Dendreon also got a new president and CEO on July 28—Amick—replacing John H. Johnson, who left the company in June. The company hired restructuring firm AlixPartners LLP and investment bank Lazard earlier this year over concerns centered on its highly leveraged capital structure and its inability to generate positive free cash flow in the near term. It also hired Trinity Partners LLC, a life science strategic consulting firm, to prepare a valuation report and develop independent revenue forecast models. In its latest Form 10-Q, filed Monday, Dendreon reported a $73.72 million net loss on $224.11 million in revenue for the nine months ended Sept. 30. The company lost $208.06 million on $208.91 million over the same period a year earlier. Dendreon listed $340.26 million in assets and $660.73 million in liabilities as of Sept. 30. Other than its unsecured noteholders, unsecured creditors include Savvis Communications Corp. of Chicago (owed $545,334), the American Red Cross of Pasadena, Calif. ($319,443), Vogel Farina LLC of New York ($255,280), Cisco Systems Capital Corp. of Los Angeles ($252,814) and Blood Centers of America Inc. of Boston ($190,650), the petition said. The stock, which trades on Nasdaq, was down more than 76% on Nov. 10, to 22.5 cents. It closed Nov. 7 at 94.2 cents. Dendreon is 8% owned by BlackRock Inc. and 5.8% owned by Vanguard Group. Ken Ziman and Felicia Gerber-Perlman lead a debtor counsel team at Skadden, Arps, Slate, Meagher & Flom LLP. Skadden partners Graham Robinson, Cliff Gross and James Carroll and counsel Laura Knoll lead Skadden teams advising on other aspects of the case. Sven Pfeiffer of Lazard is Dendreon’s investment banker. Steven Gartner, Gregory Astrachan and John Longmire of Willkie Farr & Gallagher LLP are advising Deerfield, while Steven Pohl of Brown Rudnick LLP represents other unidentified noteholders. n cover search view 9 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 DEALFLOW Biotechnology Value Fund leads $43.4M PIPE by GTx Financing will support clinical trials of drugs to treat breast and prostate cancer by dan lonkevich Biotechnology Value Fund LP and affiliates led a $43.4 million private placement investment in GTx Inc. (GTXI) to fund its development of treatments for breast and prostate cancers and cancer-related illnesses. Memphis, Tenn.-based GTx is issuing 64.3 million units, each consisting of a common share and a warrant to purchase a common share. The units are priced at 67.5 cents, which is an 18.4% premium to the price where GTx shares closed Nov. 7. The four-year warrants will have an exercise price of 85 cents. The amount being raised in the private placement is slightly more than GTx’s market capitalization. Shares of GTx, which are listed on the Nasdaq Global Market, fell 1 cent to 56 cents in midafternoon trading on Nov. 10, after the private placement was announced. Biotechnology Value Fund, which is managed by San Francisco-based BVF Inc., is a new investor in GTx, GTx chief legal officer Henry Doggrell said. BVF will be making the investment through four of its funds. Welsh Carson invests in Revel Systems Revel Systems said Nov. 11 it secured $100 million in Series C funding, including a $65 million investment from Welsh Carson Anderson & Stowe LP, as well as a $25 million equity line close print Other investors include GTx chairman J.R. Hyde III, who previously owned a 32% stake in the company, and Pyramid Peaks Foundation, which previously owned 8%. The money raised in the private placement will be used to support two clinical trials beginning in the first half of next year, Doggrell said. GTx expects initial results from the trials in the second half of 2016. The capital raised in the private placement should last at least through 2016, Doggrell said. GTx’s lead product enobosarm is being developed for the targeted treatment of estrogen receptor (ER) positive and androgen receptor (AR) positive breast cancer, as well as AR positive triple negative breast cancer. Results from a Phase 2 trial of enobosarm demonstrated clinical benefit at six months, the company said in June. GTx’s financing is at least the ninth private-investment-in-public-equity financing that BVF has participated in since 2011. In February, BVF invested $10 million in a $20 million PIPE by Regado Biosciences Inc. (RGDO). n from the private equity firm. The San Francisco company has said the deal values it at $400 million, according to news reports, though calls seeking comment were not returned. Revel Systems is a provider of an iPad-based point of sales platform used by restaurants and back < Index > retailers. The system executes functions such as order entry, cash register and payment processing. It also provides personnel scheduling, time clock, payroll, inventory and menu manage- cover CONTINUED > search view 10 the DEALFLOW REPORT Tu e sday November 18 2014 DEALFLOW < Previous ment and several reporting features. The company was founded in 2010. In September, Revel announced its largest technology transaction, saying it would provide iPad POS systems at Smoothie King, a beverage retailer with more than 700 locations. In a press release, Revel said that it was partnering with Welsh Carson because of the firm’s expertise in B2B operations, including payment industry processing technologies. In July 2007, Welsh Carson paid $56 million for an investment in Paycom.net LLC, a cloud computing-based payroll software provider. The company went public in July as Paycom Software Inc. (PAYC), and though it wasn’t an immediate success, has fared well lately. It trades at about $22 a share, up from its initial public offering price of $17. Welsh Carson is selling TransFirst Inc., another payroll processing provider, to Vista Equity Partners for a reported $1.5 billion, including debt. Welsh Carson invested in the operation in June 2007, paying $683 million, and has taken at least one dividend out of the company during its ownership. Meanwhile, Welsh Carson also touted its performance regarding returns to investors. The firm said it has closed its sale of Matrix Medical Network, a Scottsdale, Ariz., based provider of medical assessment services to Medicare Advantage programs, to Providence Service Corp. (PRSC). The transaction netted Welsh Carson $400 million, with $360 million cash and the rest in Providence stock. The firm said that represented a 3.1 times investment multiple and a 46% internal rate of return. Welsh Carson, speaking to the accommodating market for exits lately, noted that it has executed four sales of portfolio companies, as well as two IPOs, including the TransFirst debt. In all, Welsh Carson, which has $20 billion of capital, noted that since the beginning of 2013, amid a flurry of capital events, it has distributed to investors a $5.42 return on every dollar they invested. USA Compression gets ATM for up to $150M USA Compression Partners LP (USAC), a pro- close print vider of natural gas compression services for the oil and gas industry, said it received a $150 million at-the-market offering facility to provide working capital for general partnership purposes, including repayment of debt, acquisitions and capital expenditures. The Austin, Texas-based company will have a right to sell its common units through the selling agents on a best-efforts basis. USA Compression will have the right to establish a minimum per share purchase price. The facility was underwritten by UBS AG, Raymond James & Associates Inc., RBC Capital Markets and SunTrust Robinson Humphreys. The amount of the facility represents a 21.6% stake USA Compression, which had a market value of $694.2 million before the ATM agreement was announced Thursday. Shares of USA Compression fell $1.55 to $20.63 on the New York Stock Exchange after the financing was disclosed. Natural gas compression systems are used to transport natural gas from wells to gathering and pipeline systems, and to maintain production as reservoir pressure declines. Representatives of USA Compression couldn’t be reached for comment. The law firm of Vinson & Elkins LLP advised USA Compression, while the law firm of Latham & Watkins LLP advised the underwriters. This was the first private-investment-inpublic-equity financing for USA Compression. The company had cash and cash equivalents of $7,000 as of Sept. 30, after posting net income of $16.4 million in the first nine months of the year. USA Compression had $509,681 in longterm debt. On Deck swings for NYSE Small-business lender On Deck Capital Inc. has filed to list on the New York Stock Exchange, looking to raise up to $150 million in new capital to take advantage of the burgeoning nonbank lending market. The New York company, which has received venture funding from a number of investors including billionaire Peter Thiel and Google Ventures, said Nov. 10 in a Form S-1 registration filed with the Securities and Exchange Commission that it would look to list its shares under the ticker ONDK. back < Index > It did not provide a price range on the shares or specify how many shares it would offer. In the filing, the company touted the growing nonbank and small-business lending market, which it said was “vast and underserved.” The company cited data from management consulting firm Oliver Wyman Group, a unit of risk management and insurance brokerage firm Marsh & McLennan Cos., asserting there potentially is $80 billion to $120 billion in unmet demand for small-business lines of credit in the U.S. On Deck, launched in 2007 by financial software engineer Mitch Jacobs, provides loans and services to small businesses such as hair salons and doctors, particularly in California, Florida and New Jersey. The company will look to continue to enlarge its business following the IPO, keeping pace with the growing nonbank lending industry, which has been buoyed by big banks scaling back their personal and small-business lending operations after the financial crisis. These banks are under new regulatory pressure that make it more difficult to issue and originate new loans. To that end, On Deck has seen rapid growth over the past two years. In 2013 the company originated $458.9 million of loans, representing year-over-year growth of 165%, and in the first nine months of 2014, it originated $788.3 million of loans, representing year-over-year growth of 171%. That growth profile has led investors to On Deck before. Earlier this year, the company raised $77 million in an equity round led by Tiger Global Management LLC, bringing its total venture backing to $180 million. Some of On Deck’s most notable investors include SAP Ventures, Contour Venture Partners and former American Express Co. CEO James Robinson III, as well as PayPal Inc. co-founder Thiel and the venture arm of Google Inc. (GOOG). On Deck expects to use proceeds from the offering for general corporate purposes as well as to invest in or acquire complementary technologies, solutions or businesses and for targeted international expansion. While nonbank lending has been a hot area—Kabbage Inc., an Atlanta online financing technology and data company, recently raised cover CONTINUED > search view 11 the DEALFLOW REPORT Tu e sday N ovember 18 2014 DEALFLOW < Previous $50 million in Series D funding from investors including SoftBank Capital in May and in April secured a revolving three-year $270 million line of credit from unnamed investors—On Deck cautioned that its business has risks. “Our recent, rapid growth may not be indicative of our future growth, and, if we continue to grow rapidly, we may not be able to manage our growth effectively,” the company said, adding that it has a “history of losses and may not achieve consistent profitability in the future.” In 2013, the company generated a net loss of $24.4 million on $65.2 million in revenue, and in the nine months ended Sept. 30, it posted a net loss of $14.4 million on $107.6 million in revenue. Its cash flows seem to be improving, however, as the company posted positive Ebitda in the third quarter ended Sept. 30 of $2.6 million and net income of $400,000. If On Deck does go public, it may not be the only small-business lender to do so in the coming months. LendingClub Corp., which provides and facilitates peer-to-peer lending and recently launched a small-business lending operation, also is preparing a potential 2014 IPO, which reportedly could value the San Francisco company at more than $4 billion. Morgan Stanley, Raymond James & Associates Inc., Bank of America Merrill Lynch, JPMorgan, Stifel, Nicolaus & Co., Deutsche Bank Securities Inc., Needham & Co. and Jefferies LLC are underwriting the On Deck offering. Larry W. Sonsini, Tony Jeffries and Damien Weiss with the law firm Wilson Sonsini Goodrich & Rosati PC provided outside counsel, as did Christopher J. Austin, Andrew D. Thorpe and Stephen C. Ashley of the Orrick, Herrington & Sutcliffe LLP law firm. The company’s general counsel is Cory Kampfer. On Deck did not respond to calls for comment. Intrepid flies toward IPO Intrepid Aviation Ltd. filed Wednesday for an initial public offering, joining the wave of air leasing firms looking for liquidity after a strong run of success. Stamford, Conn.-based Intrepid filed to raise up to $150 million for purposes of determining close print its registration fee, but did not detail a number of shares to be sold or give an estimation of price. The company’s principal shareholders include Reservoir Capital Group LLC and Centerbridge Partners LP. Intrepid is the owner of a fleet of 16 mostly long-range Boeing Co. and Airbus SAS aircraft with a book value of $1.7 billion as of June 30. The planes are leased to 13 airlines including Alitalia SpA, Air France SA, Skymark Airlines Inc. and Air Namibia. The company has commitments to purchase 17 more new aircraft by 2018, with leases in place for 10 of the committed aircraft to join airline fleets. Intrepid recorded a net loss of $4.8 million on $73.2 million in revenue for the six months ending June 30, 2014. Intrepid is going public during a strong period of success for air leasing firms. Airline customers flush with capital after a wave of restructurings are racing to renew their fleets with more fuel-efficient aircraft, and are increasingly turning to leasing firms instead of acquiring new jets. The company estimates that about 40% of the global commercial fleet is under lease today, compared to just 2% in 1980. Boeing’s capital arm forecast that leasing will account for more than half of the global fleet by the end of the decade. The filing continues a rush of activity among air leasing firms. Earlier this year, AerCap Holdings NV (AER) completed a $5.4 billion deal to acquire International Lease Finance Corp. from American International Group Inc. (AIG), while the massive air leasing arm of General Electric Co. in October said it would buy IPO-candidate Milestone Aviation Group for $1.78 billion. Another large lessor, Avolon Holdings Ltd., has also filed to go public, and analysts have predicted that additional IPOs and dealmaking is likely due to heavy private equity interest in the sector and the advantages of having scale. Goldman, Sachs & Co., Bank of America Merrill Lynch, Deutsche Bank Securities Inc., Jefferies LLC, RBC Capital Markets, Wells Fargo Securities LLC, Credit Agricole CIB and BNP Paribas are all listed as underwriters on the offering. Marc D. Jaffe and Erika L. Weinberg of the Latham & Watkins LLP law firm are serving as counsel to the company. Michael Kaplan of the law firm Davis Polk & back < Index > Wardwell LLP is acting as underwriter counsel. Peak readies run at IPO Ski resort operator Peak Resorts Inc. hopes to cut its debt load by about 43%, lowering its high cost of capital, with an initial public offering that could raise around $100 million. The bulk of Peak’s debt bears interest at rates between 10% and 11%, and according to one investment banker familiar with the ski resort space, a capital cost in that range is not uncommon for cold-weather resorts. Investors and lenders “tend to see coldweather resorts as higher-risk than their alternatives. ... I think the risk factor is exaggerated in the eyes of investors and lenders,” said the investment banker, who requested anonymity. The Wildwood, Mo., company in Securities and Exchange Commission filings Nov. 10 said it planned to sell 10 million shares at a price between $9 and $11 per share, yielding an estimated $91.6 million in proceeds. Peak Resorts plans to use those proceeds to cut its long-term debt load to $99 million from $174.8 million; the remainder of the proceeds would go toward general corporate purposes, acquisitions and a $5 million fee related to early debt repayments to its lender. The fee is linked to a debt restructuring agreement, announced Nov. 10. The restructuring will allow for some early debt repayments, extends certain maturity dates and gives lender EPR Properties (EPR) a right of first refusal to provide new financing, among other modifications. Following the IPO, the company intends to pay quarterly cash dividends of 13.75 cents per share on its common stock beginning in February 2015. Shares would trade on Nasdaq under ticker symbol SKIS. Peak previously had aimed to launch an IPO in 2011, but it delayed the effort due to volatile market conditions. The company operates 13 resorts—12 owned by Peak as well—in the Midwest, Northeast and Southeast. According to the investment banking source, Peak’s management team is a “very sophisticated and intelligent group” of handson managers with a good understanding of their core market. cover CONTINUED > search view 12 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 DEALFLOW < Previous A second source familiar with the company noted Peak’s IPO is priced “pretty high” in terms of the company’s enterprise value as a multiple of earnings. Peak isn’t the only ski resort operator to turn to the equity capital markets this year. Intrawest Resorts Holdings Inc. (SNOW), which owns or has interests in seven ski resorts, received $29 million in net proceeds from an IPO on Feb. 5 priced at $12 per share. (Owner Fortress Investment Group LLC (FIG) also sold 14.84 million shares, but Intrawest received no proceeds from the sale by the private equity firm.) The investment banking source said that, generally speaking, cold-weather-oriented resort companies are “constantly” in talks with their existing lenders and investors, and potential new lenders and investors, to find ways to cut their cost of capital. The second source, however, said the ski resort industry is fragmented, with many companies owning just one or a few resorts. Unlike Peak or Intrawest, most of them wouldn’t be in a position to improve their financing cost through an IPO. Peak recorded $15 million in income on $105.21 million in revenue for the fiscal year ended April 30, compared with $16.92 million in income on $99.69 million in revenue the previous year, $3.52 million in income on $82.04 million in revenue in fiscal 2012 and $16.77 million in income on $97.59 million in revenue in fiscal 2011. As of July 31, the company had $204.36 million in assets, including about $6 million in cash and $10.96 million in restricted cash, and it had $10 million in liquidity available under various loan agreements. The company had $175.08 million in debt. Peak noted in a Nov. 10 regulatory filing that it relies on EPR Properties for most of its financing. The Kansas City, Mo., REIT has $3.9 billion in investments in entertainment, recreation and education properties. Peak’s debt structure consists of $63.5 million in 10.93% secured notes due April 3, 2027, related to its Attitash and Mount Snow properties; $42.91 million in 10% secured notes due April 1, 2016, related to the Mount Snow property; $47.03 million on a 9.98% secured close print credit facility due Oct. 29, 2027; $10.97 million in 10.27% secured notes due March 10, 2027, related to the Crotched Mountain property; $4.55 million in 10.2% secured notes due Dec. 29, 2032, related to the Sycamore Lake property; $3.92 million in 4% secured notes due Dec. 22, 2020, related to its Wildcat Mountain property; and $2.2 million in other, unspecified debt. Substantially all of the company’s assets serve as collateral for its long-term debt. The debt restructuring will allow Peak to prepay up to $76.2 million in debt, in exchange for the prepayment fee of up to $5 million, as long as it raises at least $44.9 million in proceeds from the IPO. The deal also will cancel existing purchase options EPR had for some of Peak’s properties and replace them with options to purchase the Boston Mills, Brandywine, Jack Frost, Big Boulder and Alpine Valley resorts. The restructuring also will extend maturity dates on the company’s loans related to those properties by seven years and, separately, remove an option to lower the interest rates on its debt if the company meets targets related to its debt service coverage ratio. Following the restructuring, EPR will have the first right of refusal on any financing related to new or existing properties for seven years. After the IPO, Peak anticipated its three top officers, CEO and chairman Timothy D. Boyd, CFO Stephen J. Mueller and vice president Richard K. Deutsch, would own 24.8% of outstanding common shares. The debt restructuring will release those executives’ personal guarantee obligations on certain debt instruments. Peak said it will use some of the IPO proceeds left after paying down debt to make acquisitions. The company has grown through acquisitions since 2002; in its biggest deal, it paid $73.5 million plus $2 million of assumed liabilities to acquire its Mount Snow and Attitash properties from American Skiing Co. in 2007. Peak and EPR representatives didn’t respond to requests for comment. Similar to the IPO market, M&A market for ski resorts has been anything but frozen this year. Colorado’s Durango Mountain Resort in October announced a planned sale to James Coleman, a managing partner of two New Mexico ski back < Index > properties, for $35 million, or 7 times Ebitda. Coleman also is buying Arizona Snowbowl in Flagstaff, Ariz. In addition, three ski deals took to the slopes in September, the largest being Vail Resorts Inc. (MTN)’s $182.5 million purchase of Park City Mountain Resort from Powdr Corp. Mammoth Resorts LLC also agreed to pay $38 million for Snow Summit Ski Corp., and Intrawest acquired the remaining 50% interest in Blue Mountain Ski Resort in Blue Mountains, Ontario, for C$58 million ($51 million). For some ski operators, however, the high cost of capital may be insurmountable. “I think a lot of ski resorts on the East Coast and in the Northeast have issues,” the second source said. “Maybe there will have to be some restructurings” among those players. Southcross Energy gets ATM for up to $75M Well Fargo Securities LLC, JPMorgan and RBC Capital Markets are providing a $75 million atthe-market offering facility to Southcross Energy Partners LP (SXE) to reduce debt and make acquisitions. The Dallas natural gas transmission company said the ATM facility had no agreed upon term. It said each sale of securities under the ATM would be subject to a soft floor. In addition, the company will be able to establish a minimum price for sales. Southcross was advised on the transaction by the law firms Latham & Watkins LLP, Gardere Wynne Sewell LLP and Richards Layton & Finger PA. The underwriters were advised by Baker Botts LLP. Representatives of Southcross couldn’t be reached for comment. This was the company’s second privateinvestment-in-public-equity financing after a $40 million convertible preferred PIPE issued to Charlesbank Capital Partners LLC in 2013. The company had cash and cash equivalents of $1.82 million as of Sept. 30, after posting a third-quarter loss of $24.8 million. Long-term debt totaled $457.9 million. n cover Have news that may be of interest to readers? Please email us at [email protected] search view 13 the DEALFLOW REPORT Tu e sday November 18 2014 Regulatory Update Crowdfunding portal Eureeca fined Investors were not accredited, SEC says by dan lonkevich Eureeca Capital SPC, a crowfunding portal formed in the Cayman Islands, has agreed to pay $25,000 to settle charges that it failed to take reasonable steps to verify the accredited status of U.S. investors. The settlement was disclosed Nov. 10 in an administrative filing with the Securities and Exchange Commission. Eureeca allegedly allowed three U.S. investors to invest $20,000 in four separate crowdfunded securities offerings. The investors and investments were not identified. Eureeca said on its website that the crowdfunding opportunities on its eureecacapital.com website were only available to non-U.S. investors, according to the SEC. Still, Eureeca allowed the three who identified themselves as U.S. investors to register on the website and invest. Two of the investors were allowed to self-certify that they were accredited by e-mail. The third was allowed to invest without certifying that they were accredited. The SEC charged Eureeca with willful violations of Sections 5(a) and 5(c) of the Securities Act and with willful violations of Section 15(C). The commission said it accepted Eureeca’s offer to settle the matter because it took immediate remedial actions after being approached by securities regulators. Eureeca was not registered with the SEC. Numerous crowdfunding portals like Eureeca, which host online offerings of unregistered securities, have launched since the passage of the Jumpstart Our Business Startups Act in 2012. The JOBS Act included provisions that were meant to allow crowdfunded securities offerings that would be open to unaccredited investors. However, the SEC has not yet made rules to implement those provisions, so portals like Eureeca have generally restricted themselves to marketing securities to accredited investors. The Securities Act generally defines an accredited investor as a person whose annual income exceeds $200,000, or $300,000 with their spouse, or who has a net worth of at least $1 million, excluding the value of their primary residence. SEC officials couldn’t be reached for comment on the action and whether similar actions are likely to follow against other crowdfunding portals. The action against Eureeca “is one of a few I’m aware of,” said Douglas Ellenoff, a member of law firm of Ellenoff Grossman & Schole LLP, who has advised several crowdfunding platforms on securities law. The action “is consistent with the inquiries we’re getting from regulators on behalf of our own clients with no fallout.” With the action, the SEC “is reminding people that when they use the Internet to raise money, they have to follow the rules,” Ellenoff said. Other enforcement actions are likely to follow against other crowdfunding portals, although the problem of portals admitting nonaccredited investors is “not pervasive,” he said. “The funding platforms I know of have spent the better part of the last two years informing themselves about the rules of the JOBS Act and are trying to comply,” Ellenoff said. Representatives of Eureeca could not be reached for comment. n Former DGSE CEO ordered to repay company L.S. Smith to reimburse jewelry company for compensation based on faulty accounting by dan lonkevich Dr. L.S. Smith, the former chairman and CEO of DGSE Companies Inc. (DGSE), was ordered Wednesday to reimburse the Dallas jewelry company $106,250 and 59,738 shares he received as compensation, because of an accounting scandal that occurred during his tenure as CEO. The company consented to a settlement with the Securities and Exchange Commission over the accounting irregularities in May, which CEO Dusty Clem said involved no fines after DGSE replaced management. At the same time, I. John Benson, who was close print CFO during Smith’s tenure as CEO, agreed to pay $75,000 to settle charges brought by the SEC in connection with the accounting scandal, which involved financial reporting, books and records and internal control violations. The SEC said the accounting irregularities were caused by fraudulent accounting entries made or directed by Benson, which overstated inventory. The entries went undetected because of DGSE’s failure to maintain appropriate accounting systems, policies, procedures and controls, the SEC said. Under the Sarbanes-Oxley Act of 2002, Smith was required to reimburse the company back < Index > for his incentive compensation and stock sale profits he received during the relevant period. The SEC said it brought the administrative proceeding against Smith, seeking the reimbursement, after he failed to repay the stock and cash on his own. Smith, who was chairman and CEO of DGSE from 1980 until 2011, was not alleged to have participated in any wrongdoing. Clem declined to comment further. Smith didn’t immediately respond to an e-mailed request for comment. Shares of DGSE fell 1 cent to $1.05 Thursday on the NYSE MKT. n cover search view 14 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 DATES & DEADLINES Important events coming up in the small-cap financing market: • Second Sight Medical Products Inc., a Sylmar, Calif., company that makes devices to return some vision to blind people, is planning to raise $32 million in an initial public offering this week, according to Dealogic plc. It will price 3.5 million shares at $9 each. Its underwriter is MDB Capital Group LLC. • EHi Car Services Ltd. is planning to raise $130 million this week through the sale of 20 million shares priced from $12 to $14 each. JPMorgan and Goldman Sachs (Asia) LLC are underwriting the offering. EHi is one of the largest car service and rental providers in China. • The Irvine, Calif., burger chain Habit Restaurants Inc. is planning a $75 million IPO Wednesday. It plans to offer 5 million shares priced from $14 to $16 each. Underwriters include Piper Jaffray & Co., Robert W. Baird & Co., Wells Fargo Securities LLC, Raymond James & Associates, Stephens Inc. and Stifel, Nicolaus & Co. • Neothetics Inc., a San Diego company that makes products for plastic surgery, is planning to sell 4.3 million share in an IPO Wednesday. Shares will price from $13 to $15 each. Underwriters include Piper Jaffray, Guggenheim Securities LLC and Needham & Co. LLC. • Neff Corp., a Miami-based construction equipment rental company, is planning to raise $220 million in an IPO Thursday. Neff will offer 10.4 million shares for between $20 and $22 each. Underwriters include Morgan Stanley & Co. LLC, Jefferies, Piper Jaffray, Bank of America Merrill Lynch and Wells Fargo. • Ski resort operator Peak Resorts Inc. is planning a $100 million IPO Thursday. Peak, based in Wildwood, Mo., will offer 10 million shares priced from $9 to $11 each. The offering is underwritten by FBR Capital Markets & Co., Stifel and others. • Roth Capital Parners LLC hosts its Software Corporate Day Nov. 18 in San Francisco. • Stifel, Nicolaus & Co. holds its Healthcare Conference Nov. 18 and 19 in New York. close print • Mitsubishi UFJ Securities (USA) Inc. hosts its Oil and Gas Conference, Nov. 18 in New York. • Scotiabank’s Energy Infrastructure Conference in Toronto takes place Nov. 18. • Deutsche Bank’s Small and Mid Cap Conference in Coral Gables, Fla., will be held Nov. 18 and 19. • Mitsubishi UFJ Securities (USA) Inc. holds its Property REIT Conference, Nov. 19 in New York. • The Global Paper and Packaging Conference, presented by Vertical Research Partners, takes place Nov. 19 in New York. • Keefe Bruyette & Woods Inc. holds its Brokerage & Market Structure Conference in New York, Nov. 20. • Canaccord Genuity’s Medical Technology & Diagnostic Form is held Nov. 20 in New York. • JPMorgan holds its Asia Rising Dragons Forum in Kuala Lumpur, Singapore, Hong Kong and Tokyo, from Nov. 20 to 28, focusing on high-growth stocks across Asia. • The Securities and Exchange Commission holds its annual Government-Business Forum on Small Business Capital Formation in Washington, Nov. 20. The morning session of the forum will feature panel discussions on the definition of an accredited investor and secondary market liquidity for securities of small businesses. During the afternoon session, participants will work in groups to formulate specific policy recommendations. Register online here: https://tts.sec. gov/cgi-bin/registration-sbf. • The Financial Industry Regulatory Authority holds its South Region Compliance Seminar Nov. 20 and 21 in Fort Lauderdale, Fla. • BIOFest, held by Deutsche Bank in Boston, takes place Dec. 1 and 2. • Credit Suisse Securities (USA) LLC presents its Technology Conference, Dec. 1 to 4 in Scottsdale, Ariz. • JPMorgan holds its Fixed Income Market Outlook 2015 conference on Dec. 2 in New York, which includes emerging market coverage. back < Index > cover • Scotiabank’s Mining Conference in Toronto takes place Dec. 2 and 3. • Nasdaq QMX holds its 31st Investor Program in London on Dec. 2 and 3. • LD Micro Conference sponsored by Roth Capital Partners LLC takes place in Los Angeles, Dec. 2 to 4. • Mitsubishi UFJ Securities (USA) Inc. holds its Oil & Gas Conference Dec. 3 in New York. • Credit Suisse Securities (USA) LLC holds its Global Industrials Conference Dec. 3 to 5 in New York. • Starlight Capital presents its Private Equity Conference Dec. 4 in New York. • Jefferies LLC holds its Financial Institutions Group CEO Summit Dec. 8 in New York. • UBS Securities LLC’s 42nd Annual Global Media & Communications Conference takes place in New York, Dec. 8 to 10. • JPMorgan’s SMid Cap Conference takes place Dec. 10 and 11 in Chicago. • Oppenheimer & Co.’s 25th annual Healthcare Conference takes place Dec. 10 and 11 in New York. • Roth Capital Partners LLC hosts its 17th annual BIO CEO & Investor Conference Feb. 9 and 10 in New York. • JPMorgan holds its Emerging Markets Year Ahead: Investment Ideas 2015 conference in London Dec. 10. • Tech Forum at the 2015 CES will be held by JPMorgan in Las Vegas, Nev., Jan. 6. • JPMorgan’s 33rd Healthcare Conference will be held in San Francisco, Jan. 12 to 16. • Needham & Co. LLC holds its 17th annual Growth Conference Jan. 13 to 15 in New York. • Noble Research holds its 11th annual investor conference, D2, in Sandpiper Bay, Fla., Jan. 18 to 21. • The 14th Annual Private Equity Conference takes place Feb. 20 in Chicago, hosted by Beecken Petty O’Keefe & Co. • Roth Capital Partners LLC hosts its 27th annual Roth Conference March 8 to 11 in Laguna Niguel, Calif. • Growth Capital Expo, held by MarketNexus Media, will be held April 12 and 14 in Las Vegas. n search view 15 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 Small Cap Equity Finance Activity PIPE Transaction activity for the period NOVEMBER 3 through NOVEMBER 14, 2014 Status* C/A Date** C C C C C C C DA C A C A A DA C DA C C C C DA DA C DA C C C C C C C C C C C A DA C C C DA C DA DA C C 11/13/14AxoGen Corp.AXGNNASDAQ-CM $3,550,000 Common Stock 11/13/14AxoGen Corp.AXGNNASDAQ-CM $1,749,999 Common Stock 11/13/14CTI BioPharma Corp.CTICNASDAQ-CM $35,000,000 Pref: Conv 11/13/14 Evoke Pharma Inc. EVOKNASDAQ-CM $6,600,000 At-the-Market Offering 11/13/14 Mast Therapeutics Inc. MSTXNYSE MKT $14,851,729 Common Stock 11/13/14 Mast Therapeutics Inc. MSTXNYSE MKT $6,148,271 Prepaid Warrant 11/13/14ORBCOMM Inc. ORBCNASDAQ-GS $82,799,998 Common Stock 11/12/14 Lightbridge Corp. LTBRNASDAQ-CM $5,037,403 Common Stock 11/12/14Southcross Energy Partners LPSXENYSE $75,000,000 At-the-Market Offering 11/12/14Strata-X Energy Ltd.STRXFOTC $3,179,050 Common Stock 11/12/14USA Compression Partners LPUSACNYSE $150,000,000 At-the-Market Offering 11/11/14Aberdeen International Inc.AABVFOTC $1,761,000 Common Stock 11/11/14Cheniere Energy Inc. LNGNYSE MKT $1,500,000,000 Debt: Conv 11/10/14Amarantus BioScience Holdings Inc.AMBSOTC $3,000,000 Pref: Conv 11/10/14 BioPharmX Corp. BPMXOTC BB $9,037,546 Pref: Conv 11/10/14Cheniere Energy Inc. LNGNYSE MKT $1,000,000,000 Debt: Conv 11/10/14Dynavax Technologies Corp.DVAXNASDAQ-CM $50,000,000 At-the-Market Offering 11/10/14Geo Group Inc.GEONYSE $100,000,000 At-the-Market Offering 11/10/14OXIS International Inc.OXISOTC $1,250,000 Debt: Conv 11/10/14ROI Land Investments Ltd.ROIIOTC BB $6,155,475 Common Stock 11/9/14GTx Inc.GTXINASDAQ-GM $43,410,001 Common Stock 11/7/14American Superconductor Corp.AMSCNASDAQ-GS $10,000,000 Common Stock 11/7/14 Biolase Inc. BIOLNASDAQ-CM $34,999,999 Common Stock 11/7/14Cadiz Inc.CDZINASDAQ-GM $12,210,120 Common Stock 11/7/14Clean Diesel Technologies Inc.CDTINASDAQ-CM $4,348,313 Common Stock 11/7/14Cymabay Therapeutics Inc.CBAYNASDAQ-CM $25,000,000 At-the-Market Offering 11/7/14 EnLink Midstream Partners LP ENLKNYSE $350,000,000 At-the-Market Offering 11/7/14 InspireMD Inc.NSPRNYSE MKT $8,140,400 Common Stock 11/7/14 Pernix Therapeutics Holdings Inc. PTXNASDAQ-GM $100,000,000 At-the-Market Offering 11/7/14 Prospect Capital Corp. PSECNASDAQ-GSUnknownAt-the-Market Offering 11/7/14Solar Power Inc.SOPWOTC $48,250,800 Common Stock 11/7/14StationDigital Corp.SDIGOTC $1,000,000 Debt: Conv 11/6/14Amedica Corp.AMDANASDAQ-CM $1,000,000 Debt: non-Conv 11/6/14Coronado Biosciences Inc.CNDONASDAQ-CM $3,501,750 Common Stock 11/6/14Sunoco Logistics Partners LPSXLNYSE $1,000,000,000 At-the-Market Offering 11/6/14Vapor Corp.VPCONASDAQ-CM $1,000,000 Debt: Conv 11/6/14 Xinergy Ltd. XRGYFOTC $25,000,000 Debt: Conv 11/6/14 Zogenix Inc. ZGNXNASDAQ-GM $25,000,000 At-the-Market Offering 11/5/14Acorn Energy Inc.ACFNNASDAQ-GM $4,500,000 Common Stock 11/4/14Applied Minerals Inc.AMNLOTC $12,500,000 Debt: Conv 11/4/14NewStar Financial Inc.NEWSNASDAQ-GS $200,000,000 Debt: non-Conv 11/3/14Aerie Pharmaceuticals Inc.AERINASDAQ-GM $50,000,000 At-the-Market Offering 11/3/14Crimson Forest Entertainment Group Inc.CRIMOTC BB $5,000,000 Common Stock 11/3/14Oramed Pharmaceuticals Inc.ORMPNASDAQ-CM $5,000,000 Common Stock 11/3/14Vanda Pharmaceuticals Inc.VNDANASDAQ-GM $66,700,000 Common Stock 11/3/14 WidePoint Corp. WYYNYSE MKT $11,500,001 Common Stock Issuer Ticker Exchange Amount Security Type *Status: C = Closed, DA = Definitive Agreement, A = Announced, I = Intended, p + Postponed, X = Canceled. ** C/A Date: Best Available of (i) Closing Date, (ii) Definitive Agreement Date or (iii) Announced Date. *** Excludes all PIPEs executed by foreign-based Issuers that trade on the Over-The-Counter market (Pink Sheets). All data is based on proprietary information from PrivateRaise, a service of The Deal. Data includes PIPEs that are at least US$1.0 million and have been executed by public corporations domiciled in the U.S. or by public, foreign companies that have primary listing or a significant or consistent trading presence on a U.S. stock exchange or market. Data is updated based on availabilty of public disclosures (e.g. press releases and SEC filings) and has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. League tables exclude equity lines, at-the-market offerings, corporate investors, and PIPEs executed by foreign-based issuers that trade on the Over-The-Counter market (Pink Sheets). close print back < Index > cover search view 16 the DEALFLOW REPORT Tu e sday November 18 2014 Small Cap Equity Finance Activity PIPE TRANSACTION ACTIVITY FOR 2014 YEAR-TO-DATE PIPEs Issuance by Security Type Security Type Common Stock Pref: Conv Pref: non-Conv Debt: Conv Debt: non-Conv Other: Conv Prepaid Warrant Equity Line At-the-Market Offering Unknown Totals # Total $ 535 102 4 119 26 2 14 60 130 - 992 $16,256,334,685 $3,340,066,279 $76,510,000 $3,839,796,631 $719,498,531 $780,000,000 $546,305,047 $641,950,000 $16,147,159,000 - $42,347,620,173 PIPEs Issuer Market Capitalization Avg. $ Issuer Market Cap $30,385,672 $32,745,748 $19,127,500 $32,267,199 $27,673,020 $390,000,000 $39,021,789 $11,068,103 $136,840,331 $43,300,225 # Total $ Avg. $ Less than $50 M 418 $2,556,452,360 $6,160,126 $50 M - $99 M 185 $2,027,502,044 $11,019,033 $100 M - $249 M 141 $3,625,055,432 $26,079,535 $250 M - $499 M 96 $4,645,316,930 $48,898,073 $500 M - $999 M 52 $2,750,721,400 $53,935,714 $1 B - $4.9 B 67 $11,736,573,973 $189,299,580 Greater than $5 B 25 $14,982,471,883 $624,269,662 Totals 984 $42,324,094,022 $43,633,087 Total Placements (Issuer Market Capitalization & Security Type) Security Type Less $50 M Common Stock Pref: Conv Pref: non-Conv Debt: Conv Debt: non-Conv Other: Conv Prepaid Warrant Equity Line At-the-Market Offering Unknown $50 M - $99 M $100 M - $249 M $250 M - $499 M $500 M - $999 M 213 60 3 69 15 - 2 44 12 - 124 13 - 19 3 - 4 8 14 - 80 14 - 9 3 1 3 8 23 - 60 5 - 6 3 - 3 - 19 - $1 B - $4.9 B 27 2 1 6 2 - 1 - 13 - 20 6 - 6 - - - - 35 - $50 M - $99 M $100 M - $249 M $250 M - $499 M $500 M - $999 M $1 B - $4.9 B Greater $5 B 5 1 3 1 1 14 - Total Dollars Raised/Secured (Issuer Market Capitalization & Security Type) Security Type Less $50 M Common Stock Pref: Conv Pref: non-Conv Debt: Conv Debt: non-Conv Other: Conv Prepaid Warrant Equity Line At-the-Market Offering Unknown $1,347 $361 $27 $291 $96 - $8 $333 $93 - $1,239 $145 - $242 $26 - $16 $106 $254 - $1,993 $204 - $164 $53 $30 $18 $203 $960 - $2,370 $677 - $216 $245 - $22 - $1,115 - $1,137 $16 $50 $236 $300 - $11 - $1,000 - Greater $5 B $3,543 $1,535 - $959 - - - - $5,700 - $4,606 $400 $1,730 $750 $471 $7,025 - PIPE Activity - by Price Type Fixed-Price Security Type Common Stock Preferred Stock: Convertible Debt: Convertible Other: Convertible Prepaid Warrant Equity Line At-the-Market Offering Totals # 525 91 99 2 14 1 - 732 Reset-Price Variable-Price Total $M Avg. $M # Total $M Avg. $M # Total $M $16,214.06 $2,504.32 $3,613.96 $780.00 $546.31 $25.00 - $23,683.65 $30.88 $27.52 $36.50 $390.00 $39.02 $25.00 - $32.35 10 7 6 - - - - 23 $42.27 $577.15 $46.24 - - - - $665.66 $4.23 - $82.45 4 $7.71 14 - - - - - 59 - 130 $28.94 207 - $258.60 $179.60 - - $616.95 $16,147.16 $17,202.31 Avg. $M $64.65 $12.83 $10.82 $136.84 $89.13 All data is based on proprietary information from PrivateRaise, a service of The Deal. Data includes PIPEs that are at least US$1.0 million and have been executed by public corporations domiciled in the U.S. or by public, foreign companies that have primary listing or a significant or consistent trading presence on a U.S. stock exchange or market. Data is updated based on availabilty of public disclosures (e.g. press releases and SEC filings) and has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. League tables exclude equity lines, at-the-market offerings, corporate investors, and PIPEs executed by foreign-based issuers that trade on the Over-The-Counter market (Pink Sheets). close print back < Index > cover search view 17 the DEALFLOW REPORT Tu e sday N ovember 18 2014 Small Cap Equity Finance Activity PIPE TRANSACTION ACTIVITY FOR 2014 YEAR-TO-DATE Investment Managers RANKED BY TOTAL DOLLARS INVESTED Rank Investment Manager 1 RRJ Management (HK) Ltd. 2 Luxor Capital Group 3 Clayton, Dubilier & Rice Inc. 4 Caisse de depot et placement du Quebec 5 Blackstone Group LP 6 Energy Transfer Equity LP 7 PSP Investments 8 Deerfield Management Co. LP 9 Wellington Management Co. LLP 10 Public Investment Corp. (SOC) Ltd. 11 Government of Singapore Investment Co. Pte Ltd. 12 Pershing Square Capital Management LP 13 Franklin Square Capital Partners 14 P2 Capital Partners LLC 15 Magnetar Capital LLC 16 Corvex Management LP 17 Relational Investors LLC 17 General Atlantic Partners LLC 19 Invesco Ltd. 20 Sabby Management LLC 21 Baupost Group LLC 22 Avenue Capital Group LLC 23 Ontario Teachers’ Pension Plan Board 23 Sycamore Partners LLC 25 Putnam Investment Management LLC RANKED BY # OF INVESTMENTS Total $M Avg. $M $1,000.00 $1,000.00 530.00 106.00 500.00 500.00 471.01 471.01 416.00 138.67 400.00 400.00 350.00 175.00 313.50 62.70 293.54 * 26.69 * 270.00 270.00 250.00 125.00 240.65 240.65 200.00 200.00 175.00 175.00 165.58 41.39 159.98 79.99 150.00 150.00 150.00 150.00 120.89 40.30 107.61 * 4.30 * 106.73 106.73 103.16 34.39 100.00 50.00 100.00 100.00 81.80 81.80 # 1 5 1 1 3 1 2 5 12 1 2 1 1 1 4 2 1 1 3 31 1 3 2 1 1 *EXCLUDES transactions where Investment Amount has not yet been disclosed Rank Investment Manager 1 Sabby Management LLC 2 Downsview Capital Inc. 3 LH Financial Services Corp. 4 Hudson Bay Capital Management LP 5 Heights Capital Management Inc. 6 Equitec Group LLC 7 Empery Asset Management LP 7 Brio Capital LP 9 Wellington Management Co. LLP 10 Diker Management LLC 10 Iroquois Capital LP 10 Anson Capital LP 13 Crede Capital Group LLC 13 Kingsbrook Partners LP 15 Milfam LLC 15 Magna Management LLC 15 Midsummer Capital LLC 15 Sandor Advisors LLC 15 Chardan Capital Markets LLC 20 Luxor Capital Group 20 Deerfield Management Co. LP 20 Whitebox Advisors Inc. 20 Great Point Partners LLC 20 Broadfin Capital LLC 20 Oracle Investment Management Inc. Total $M $107.61 * 17.59 26.68 * 68.29 * 44.39 * 4.02 * 22.46 4.05 293.54 * 18.17 4.90 4.17 * 39.62 * 5.05 13.81 11.54 3.60 1.03 0.50 530.00 313.50 80.41 23.94 * 17.25 16.47 * Avg. $M $4.30 * 0.73 1.33 * 3.59 * 2.47 * 0.24 * 1.73 0.31 26.69 * 1.82 0.49 0.46 * 6.60 * 0.72 2.30 1.92 0.60 0.17 0.08 106.00 62.70 16.08 5.98 * 3.45 4.12 * # 31 24 21 20 19 18 13 13 12 10 10 10 7 7 6 6 6 6 6 5 5 5 5 5 5 *EXCLUDES transactions where Investment Amount has not yet been disclosed Placement Agents RANKED BY TOTAL DOLLARS RAISED Rank Placement Agent 1 Morgan Stanley & Co. 2 Cowen and Co. LLC 3 Jefferies Group LLC 4 Barclays Capital Inc. 5 Piper Jaffray & Co. 6 Roth Capital Partners LLC 7 H.C. Wainwright & Co. 8 Canaccord Genuity Group Inc. 9 Deutsche Bank AG 10 Maxim Group LLC 11 RS Platou Markets AS 12 Citigroup Global Markets Inc. 13 JMP Group Inc. 14 Craig-Hallum Capital Group LLC 15 Credit Suisse Group 16 Stifel 17 Oppenheimer & Co. 18 Nomura Holdings Inc. 19 Ladenburg Thalmann & Co. 20 BTIG LLC 21 Chardan Capital Markets LLC 22 Needham & Co. 23 CRT Capital Group LLC 24 CJS Securities Inc. 24 UBS AG RANKED BY # OF PLACEMENTS Total $M $1,440.00 885.37 805.19 672.58 655.56 649.99 643.37 560.32 545.16 531.18 527.25 505.30 455.06 449.92 436.84 409.23 366.34 346.20 342.96 337.20 330.45 323.35 305.20 300.20 300.20 Avg. $M $288.00 29.51 53.68 112.10 54.63 20.31 17.39 28.02 136.29 19.67 175.75 168.43 50.56 20.45 145.61 31.48 52.33 173.10 38.11 112.40 19.44 40.42 152.60 300.20 300.20 # 5 30 15 6 12 32 37 20 4 27 3 3 9 22 3 13 7 2 9 3 17 8 2 1 1 Rank Placement Agent 1 H.C. Wainwright & Co. 2 Roth Capital Partners LLC 3 Cowen and Co. LLC 4 Maxim Group LLC 5 Craig-Hallum Capital Group LLC 6 Canaccord Genuity Group Inc. 7 Chardan Capital Markets LLC 8 Jefferies Group LLC 9 Laidlaw & Co. (UK) Ltd. 10 Stifel 10 Northland Securities Inc. 12 Piper Jaffray & Co. 13 Aegis Capital Corp. 14 JMP Group Inc. 14 Ladenburg Thalmann & Co. 14 William Blair & Co. LLC 14 Brean Capital LLC 18 Needham & Co. 18 Dawson James Securities 20 Oppenheimer & Co. 20 MLV & Co. LLC 20 BMO Financial Group 20 Merriman Capital Inc. 24 Barclays Capital Inc. 24 Noble Financial Group Total $M $643.37 649.99 885.37 531.18 449.92 560.32 330.45 805.19 136.93 409.23 115.48 655.56 159.03 455.06 342.96 258.12 217.32 323.35 106.86 366.34 248.19 195.25 37.37 672.58 184.60 Avg. $M $17.39 20.31 29.51 19.67 20.45 28.02 19.44 53.68 9.78 31.48 8.88 54.63 15.90 50.56 38.11 28.68 24.15 40.42 13.36 52.33 35.46 27.89 5.34 112.10 30.77 # 37 32 30 27 22 20 17 15 14 13 13 12 10 9 9 9 9 8 8 7 7 7 7 6 6 All data is based on proprietary information from PrivateRaise, a service of The Deal. Data includes PIPEs that are at least US$1.0 million and have been executed by public corporations domiciled in the U.S. or by public, foreign companies that have primary listing or a significant or consistent trading presence on a U.S. stock exchange or market. Data is updated based on availabilty of public disclosures (e.g. press releases and SEC filings) and has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. League tables exclude equity lines, at-the-market offerings, corporate investors, and PIPEs executed by foreign-based issuers that trade on the Over-The-Counter market (Pink Sheets). close print back < Index > cover search view 18 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 Small Cap Equity Finance Activity PIPE TRANSACTION ACTIVITY FOR 2014 YEAR-TO-DATE Investor Legal Counsel RANKED BY TOTAL DOLLARS ADVISED Rank Investor Legal Counsel 1 Skadden, Arps, Slate, Meagher & Flom LLP 2 Schulte Roth & Zabel LLP 3 Simpson, Thacher & Bartlett LLP 4 Fangda Partners 4 Walkers Global 6 Sullivan & Cromwell LLP 7 Ropes & Gray LLP 8 O’Melveny & Myers LLP 8 Torys LLP 8 Weil, Gotshal & Manges LLP 11 Debevoise & Plimpton LLP 12 Akin, Gump, Strauss, Hauer & Feld LLP 13 Sidley Austin LLP 14 Latham & Watkins LLP 15 Paul Hastings LLP 16 Greenberg Traurig LLP 17 Andrews Kurth LLP 18 Jones Day 19 Paul, Weiss, Rifkind, Wharton & Garrison LLP 20 Katten Muchin Rosenman LLP 21 Wachtell, Lipton, Rosen & Katz 22 Lowenstein Sandler LLP 23 Willkie Farr & Gallagher LLP 24 Shearman & Sterling LLP 25 Baker Botts LLP RANKED BY # OF PLACEMENTS ADVISED Total $M $3,436.97 2,295.85 1,429.91 1,198.37 1,198.37 1,151.65 873.72 700.00 700.00 700.00 675.00 523.76 500.00 416.25 400.00 343.37 305.00 253.00 230.41 185.00 181.63 180.85 165.57 131.63 119.29 Avg. $M $859.24 37.64 285.98 1,198.37 1,198.37 575.82 124.82 350.00 350.00 350.00 337.50 74.82 250.00 208.12 400.00 15.61 152.50 84.33 46.08 61.67 90.82 22.61 55.19 131.63 119.29 # 4 61 5 1 1 2 7 2 2 2 2 7 2 2 1 22 2 3 5 3 2 8 3 1 1 Rank Investor Legal Counsel 1 Schulte Roth & Zabel LLP 2 Greenberg Traurig LLP 3 Ellenoff Grossman and Schole LLP 4 Lowenstein Sandler LLP 5 Ropes & Gray LLP 5 Akin, Gump, Strauss, Hauer & Feld LLP 5 Grushko & Mittman PC 8 Simpson, Thacher & Bartlett LLP 8 Paul, Weiss, Rifkind, Wharton & Garrison LLP 8 Brown Rudnick LLP 8 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC 12 Skadden, Arps, Slate, Meagher & Flom LLP 13 Jones Day 13 Katten Muchin Rosenman LLP 13 Willkie Farr & Gallagher LLP 13 Goodwin Procter LLP 13 Seward & Kissel LLP 13 Covington & Burling LLP 19 Sullivan & Cromwell LLP 19 O’Melveny & Myers LLP 19 Torys LLP 19 Weil, Gotshal & Manges LLP 19 Debevoise & Plimpton LLP 19 Sidley Austin LLP 19 Latham & Watkins LLP Total $M $2,295.85 343.37 38.11 180.85 873.72 523.76 12.60 1,429.91 230.41 110.41 26.78 3,436.97 253.00 185.00 165.57 75.00 74.80 26.53 1,151.65 700.00 700.00 700.00 675.00 500.00 416.25 Avg. $M $37.64 15.61 2.93 22.61 124.82 74.82 1.80 285.98 46.08 22.08 5.36 859.24 84.33 61.67 55.19 25.00 24.93 8.84 575.82 350.00 350.00 350.00 337.50 250.00 208.12 # 61 22 13 8 7 7 7 5 5 5 5 4 3 3 3 3 3 3 2 2 2 2 2 2 2 Total $M $2,181.48 1,924.22 1,368.17 1,354.71 1,198.37 1,120.00 1,000.00 994.21 979.19 784.53 761.07 700.00 667.25 587.81 497.00 491.97 486.01 441.31 400.00 395.00 368.62 335.00 327.20 325.20 274.26 Avg. $M $545.37 320.70 456.06 451.57 1,198.37 280.00 1,000.00 99.42 51.54 130.76 380.54 350.00 95.32 53.44 82.83 28.94 243.00 36.78 400.00 98.75 52.66 83.75 46.74 36.13 137.13 # 4 6 3 3 1 4 1 10 19 6 2 2 7 11 6 17 2 12 1 4 7 4 7 9 2 Rank Issuer Legal Counsel Total $M 1 Sichenzia Ross Friedman Ference LLP $190.62 2 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC 979.19 3 Cooley LLP 491.97 4 DLA Piper 273.71 5 Ellenoff Grossman and Schole LLP 169.69 6 Greenberg Traurig LLP 441.31 7 Latham & Watkins LLP 587.81 8 Goodwin Procter LLP 994.21 9 Ropes & Gray LLP 325.20 9 Szaferman Lakind Blumstein & Blader PC 25.66 11 Morrison & Foerster LLP 245.26 11 Morgan, Lewis & Bockius LLP 241.76 11 Dorsey & Whitney LLP 133.30 11 Fenwick & West LLP 116.01 11 Robinson Brog Leinwand Greene Genovese & Gluck PC 77.78 11 Davis Graham & Stubbs LLP 43.23 17 Reeder & Simpson PC 667.25 17 Sidley Austin LLP 368.62 17 WilmerHale 327.20 17 Haynes and Boone LLP 188.72 17 McDermott Will & Emery LLP 106.64 17 K&L Gates LLP 102.27 17 Paul Hastings LLP 86.19 17 Weintraub Tobin Chediak Coleman Grodin Law Corp. 48.01 17 Nason, Yeager, Gerson, White & Lioce PA 19.95 Avg. $M $5.78 51.54 28.94 17.11 11.31 36.78 53.44 99.42 36.13 2.85 30.66 30.22 16.66 14.50 9.72 5.40 95.32 52.66 46.74 26.96 15.23 14.61 12.31 6.86 2.85 # 33 19 17 16 15 12 11 10 9 9 8 8 8 8 8 8 7 7 7 7 7 7 7 7 7 Issuer Legal Counsel RANKED BY TOTAL DOLLARS ADVISED Rank Issuer Legal Counsel 1 Jones Day 2 Skadden, Arps, Slate, Meagher & Flom LLP 3 Baker & McKenzie LLP 4 Maples and Calder 5 TransAsia Lawyers 6 Wachtell, Lipton, Rosen & Katz 7 Sullivan & Cromwell LLP 8 Goodwin Procter LLP 9 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC 10 Cravath, Swaine & Moore LLP 11 Akin, Gump, Strauss, Hauer & Feld LLP 12 Simpson, Thacher & Bartlett LLP 13 Reeder & Simpson PC 14 Latham & Watkins LLP 15 Vinson & Elkins LLP 16 Cooley LLP 17 Torys LLP 18 Greenberg Traurig LLP 19 Baker Botts LLP 20 Proskauer Rose LLP 21 Sidley Austin LLP 22 Kirkland & Ellis LLP 23 WilmerHale 24 Ropes & Gray LLP 25 Andrews Kurth LLP RANKED BY # OF PLACEMENTS ADVISED All data is based on proprietary information from PrivateRaise, a service of The Deal. Data includes PIPEs that are at least US$1.0 million and have been executed by public corporations domiciled in the U.S. or by public, foreign companies that have primary listing or a significant or consistent trading presence on a U.S. stock exchange or market. Data is updated based on availabilty of public disclosures (e.g. press releases and SEC filings) and has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. League tables exclude equity lines, at-the-market offerings, corporate investors, and PIPEs executed by foreign-based issuers that trade on the Over-The-Counter market (Pink Sheets). close print back < Index > cover search view 19 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 Small Cap Equity Finance Activity PIPE TRANSACTION ACTIVITY FOR 2014 YEAR-TO-DATE Placement Agent Legal Counsel RANKED BY TOTAL DOLLARS ADVISED RANKED BY # OF PLACEMENTS ADVISED Rank Placement Agent Legal Counsel 1 Goodwin Procter LLP 2 Latham & Watkins LLP 3 Ellenoff Grossman and Schole LLP 4 Fried, Frank, Harris, Shriver & Jacobson LLP 5 Proskauer Rose LLP 6 Morrison & Foerster LLP 7 Covington & Burling LLP 8 Lowenstein Sandler LLP 9 Blake, Cassels & Graydon LLP 10 Morgan, Lewis & Bockius LLP 11 Schiff Hardin LLP 12 Taylor Wessing 13 Davis Polk & Wardwell LLP 14 Dechert LLP 15 Pillsbury Winthrop Shaw Pittman LLP 16 Linklaters LLP 16 Zhong Lun Law Firm 18 Sichenzia Ross Friedman Ference LLP 19 Sullivan & Cromwell LLP 20 Gornitzky & Co. 21 Choate, Hall & Stewart LLP 22 Meitar Liquornik Geva Leshem Tal Law Offices 22 White & Case LLP 24 Bingham McCutchen LLP 25 Stikeman Elliott LLP Total $M $857.03 641.89 593.19 527.25 294.83 252.99 230.84 207.53 170.73 150.00 137.33 120.90 103.50 103.33 98.75 95.00 95.00 90.68 80.00 72.45 68.44 58.65 58.65 57.10 56.95 Avg. $M $34.28 91.70 10.59 175.75 32.76 50.60 46.17 17.29 85.36 150.00 19.62 120.90 103.50 34.44 32.92 95.00 95.00 6.98 80.00 72.45 13.69 58.65 58.65 57.10 18.98 # 25 7 56 3 9 5 5 12 2 1 7 1 1 3 3 1 1 13 1 1 5 1 1 1 3 Rank Placement Agent Legal Counsel 1 Ellenoff Grossman and Schole LLP 2 Goodwin Procter LLP 3 Sichenzia Ross Friedman Ference LLP 4 Lowenstein Sandler LLP 5 Proskauer Rose LLP 6 Faegre Baker Daniels LLP 7 Latham & Watkins LLP 7 Schiff Hardin LLP 9 Morrison & Foerster LLP 9 Covington & Burling LLP 9 Choate, Hall & Stewart LLP 9 Loeb & Loeb LLP 13 Reed Smith LLP 14 Fried, Frank, Harris, Shriver & Jacobson LLP 14 Dechert LLP 14 Pillsbury Winthrop Shaw Pittman LLP 14 Stikeman Elliott LLP 14 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC 14 Troutman Sanders LLP 14 LeClairRyan PC 21 Blake, Cassels & Graydon LLP 21 Nixon Peabody LLP 21 Blank Rome LLP 21 Greenberg Traurig LLP 21 K&L Gates LLP Total $M $593.19 857.03 90.68 207.53 294.83 46.97 641.89 137.33 252.99 230.84 68.44 47.26 41.84 527.25 103.33 98.75 56.95 55.66 36.00 31.00 170.73 49.29 30.18 15.20 14.68 Avg. $M $10.59 34.28 6.98 17.29 32.76 5.87 91.70 19.62 50.60 46.17 13.69 9.45 10.46 175.75 34.44 32.92 18.98 18.55 12.00 10.33 85.36 24.64 15.09 7.60 7.34 # 56 25 13 12 9 8 7 7 5 5 5 5 4 3 3 3 3 3 3 3 2 2 2 2 2 All data is based on proprietary information from PrivateRaise, a service of The Deal. Data includes PIPEs that are at least US$1.0 million and have been executed by public corporations domiciled in the U.S. or by public, foreign companies that have primary listing or a significant or consistent trading presence on a U.S. stock exchange or market. Data is updated based on availabilty of public disclosures (e.g. press releases and SEC filings) and has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. League tables exclude equity lines, at-the-market offerings, corporate investors, and PIPEs executed by foreign-based issuers that trade on the Over-The-Counter market (Pink Sheets). Registered Offerings Expected Next 2 Weeks Issuer Exp. Date Ticker Exp. Value ($M) Deal Type CVSL Inc. 11/17/14 CVSL $60.00 FO eHi Car Services Ltd. 11/17/14 EHIC $130.00 IPO Palatin Technologies Inc. 11/17/14 PTN $51.75 FO Second Sight Medical Products Inc. 11/17/14 EYES $31.50 IPO STORE Capital Corp. 11/17/14 STRE $495.00 Paramount Group Inc. 11/18/14 PGRE Autohome Inc. 11/19/14 Cnova NV Market Value ($M) Bookrunner(s) $349.51 CANFITZ; JMPSEC; JMS $739.30 JPM; GS $34.53 PJ 9.00 - 9.00 $311.63 MCU IPO 17.00 - 19.00 $1,996.52 GS; CS; MS $2,292.50 IPO 16.00 - 19.00 $4,270.00 BOAML; MS; WLF; DB ATHM $426.62 FO $5,165.80 DB; GS 11/19/14 CNV $355.10 IPO 12.50 - 14.00 $5,815.62 MS; JPM; BOAML; CS; DB Habit Restaurants Inc. 11/19/14 HABT $75.00 IPO 14.00 - 16.00 $378.79 PJ; BAIRD; WLF; RJA Neothetics Inc. 11/19/14 NEOT $60.20 IPO 13.00 - 15.00 $185.73 PJ; GUGPAR; NEEDHM Adama Agricultural Solutions Ltd. 11/20/14 ADAM $399.50 IPO 16.00 - 18.00 $2,745.34 GS; BOAML Covenant Transportation Group Inc. 11/20/14 CVTI $48.77 FO $380.44 STEP; BCM Neff Corp. 11/20/14 NEFF $220.00 IPO 20.00 - 22.00 $488.98 MS; JEFF; PJ; BOAML; WLF Peak Resorts Inc. 11/20/14 SKIS $100.00 IPO 9.00 - 11.00 $139.82 FBR; STFL; BAIRD Viking Therapeutics Inc. 11/24/14 VKTX $55.00 IPO 10.00 - 12.00 $167.12 OPCO; RCP 15 Deals $4,800.94 Totals Range ($) 12.00 - 14.00 All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 20 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 Small Cap Equity Finance Activity SEC Registered IPOs Filed Since November 3, 2014 Issuer Nation Azure Midstream Partners LP USA Industry Ticker Utility & Energy Barington/Hilco Acquisition Corp. USA Finance Coronado Midstream Partners LP USA Utility & Energy County Bancorp Inc. USA Finance AZUR Exp. Value ($) $175.00 $40.00 ICBK Range ($) Shares (M) Market Value ($M) Bookrunner(s) Lead/Co-Manager(s) CITI; BOAML 10.00 10.00 4.6 $52.95 EARL $23.00 BAIRD; SAL Floor & Decor Holdings Inc. USA Retail FND $100.00 BOAML; GS; BAR; JPM; JEFF; CS; HLHZ; WLF Hortonworks Inc. USA Computers & Electronics HDP $100.00 GS; CS; RBC InfraREIT LLC USA Real Estate/ Property Inotek Pharmaceuticals Corp. USA Healthcare ITEK $86.25 COWEN; PJ; CG; NOM International Market Centers Inc. USA Real Estate/ Property IMC $200.00 BAR; CS; WLF; DB; JPM Intrepid Aviation Ltd. USA Finance INTR $150.00 GS; BOAML; DB; JEFF; RBC; WLF; CACIB; BNP James River Group Holdings Ltd. USA Insurance JRVR $287.50 STFL; UBS; FBR; BMOCM Momo Inc. CHN Computers & MOMO Electronics $300.00 MS; CS; JPM; CRNP New Relic Inc. USA Computers & Electronics NEWR $100.00 MS; JPM ALLENL; UBS; JMPSEC; RJA On Deck Capital Inc. USA Finance ONDK $150.00 MS; BOAML; JPM; DB; JEFF RJA; STFL; NEEDHM Rice Midstream Partners LP USA Utility & Energy RMP $425.00 BAR Smart Sand Partners LP USA Oil & Gas SSLP $100.00 GS; CS Terryville Mineral & Royalty Partners LP USA Oil & Gas TRVL $150.00 Unique Fabricating Inc. USA Textile UFAB $16.88 18 Deals $2,403.63 Totals KCM; WLF; BG SBGBM; STRH; KCM BAR 8.00 10.00 2.16 $77.53 TAGL SEC Registered IPOs Priced Since November 3, 2014 Nation Industry Pricing Date Ticker Deal Value ($M) Antero Midstream Partners LP USA Utility & Energy 11/4/14 AM $1,150.00 $25.00 Xenon Pharmaceuticals Inc. CAN Healthcare 11/4/14 XENE $41.40 Coherus BioSciences Inc. USA Healthcare 11/5/14 CHRS Nevro Corp. USA Healthcare 11/5/14 Upland Software Inc. USA Computers & Electronics Freshpet Inc. USA Food & Beverage Issuer Offer Filing Price Range ($) Relative Range Offer/ 1 Day Offer/ Bookrunner(s) Current Lead/CoManager(s) 19.00 21.00 Above 12.12 14.6 BAR; CITI; WLF; CS; JPM; MS BAIRD; BMOCM; RJA; TP; SBGBM $9.00 10.00 12.00 Below 16.67 49.11 JEFF; WLF CG $91.85 $13.50 12.00 15.00 In Range -6.59 2.96 JPM; CS NVRO $144.90 $18.00 15.00 17.00 Above 39.94 41.17 JPM; MS LEER; JMPSEC 11/5/14 UPLD $46.15 $12.00 12.00 14.00 In Range -18.75 -9.92 WBLR; RJA NEEDHM 11/6/14 FRPT $179.69 $15.00 12.00 14.00 Above 27.4 21.4 GS; CS BAIRD; STFL; STRH; CG CONTINUED > All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 21 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 Small Cap Equity Finance Activity < Previous SEC Registered IPOs Priced Since November 3, 2014 Nation Industry Pricing Date Ticker Deal Value ($M) Relative Range Offer/ 1 Day INC Research Holdings Inc. USA Healthcare 11/6/14 INCR $172.50 $18.50 17.00 20.00 In Range 10.76 Triumph Bancorp Inc. USA Finance 11/6/14 TBK $80.40 $12.00 14.00 16.00 Below Joint Corp. USA Finance 11/10/14 JYNT $19.50 $6.50 9.00 11.00 Axalta Coating Systems Ltd. USA Chemicals 11/11/14 AXTA $1,121.25 $19.50 Capnia Inc. USA Healthcare 11/12/14 CAPN $10.73 Navios Maritime Midstream Partners LP GRC Transportation 11/12/14 NAP PRA Health Sciences Inc. USA Healthcare 11/12/14 FibroGen Inc. USA Landmark Infrastructure Partners LP Issuer Offer Filing Price Range ($) Offer/ Bookrunner(s) Current GS; CS BAIRD; WLF; WBLR 6.25 5.58 SANDO; EP; WLF STFL; NOM Below 1.23 1.85 RCP; FELL MWCLLC 18.00 21.00 In Range 6.41 10.26 CITI; GS; DB; JPM; BOAML; BAR; CS; MS JEFF; UBS; BAIRD; BCM; NOM; SMFG $6.50 6.50 8.50 In Range -40.31 -40.31 MAXM DJS $121.50 $15.00 19.00 21.00 Below -8 -8 BOAML; CITI; JPM; CS; WLF DB; SGC PRAH $351.42 $18.00 20.00 23.00 Below 9 9 JEFF; CITI; KKRCLP; UBS; CS; WLF BAIRD; WBLR Healthcare 11/13/14 FGEN $145.80 $18.00 16.00 19.00 In Range GS; CITI; LEER RBC; STFL; WBLR USA Real Estate/ 11/13/14 Property LMRK $50.35 $19.00 19.00 21.00 In Range BAIRD; RJA; RBC JMS Neuroderm Ltd. ISR Healthcare 11/13/14 NDRM $45.00 $10.00 13.00 16.00 Below JEFF; COWEN OPCO; RCP Sky Solar Holdings Ltd. HKG Utility & Energy 11/13/14 SKYS $44.20 $8.00 7.00 8.00 In Range RCP NLND Virgin America Inc. USA Transportation 11/13/14 VA $306.76 $23.00 21.00 24.00 In Range BAR; DB BOAML; COWEN; GS; IMP; RJA 18 Deals $4,123.40 Totals 14.38 15.41 Lead/CoManager(s) 14.38 SEC Registered IPO Lock-up Expirations Next 2 Weeks Domicile Industry Pricing Date Ticker Deal Value ($M) Lock-up Provision JD.com Inc. CHN Computers & Electronics 5/21/14 JD $2,047.03 180 11/17/14 BOAML; UBS; ALLENL; BAR; CRNP; JEFF SunEdison Semiconductor Inc. USA Computers & Electronics 5/21/14 SEMI $107.64 180 11/17/14 DB; GS; WLF; MGL; CITI Agile Therapeutics Inc. USA Healthcare 5/22/14 AGRX $55.00 180 11/18/14 RBC; WBLR CANFITZ; JMS Superior Drilling Products Inc. USA Oil & Gas 5/22/14 SDPI $31.05 180 11/18/14 RCP FELL Heritage Insurance Holdings Inc. USA Insurance 5/22/14 HRTG $75.90 180 11/19/14 CITI DOWL; JMPSEC; WILLIS Parsley Energy Inc. USA Oil & Gas 5/22/14 PE $1,063.75 180 11/19/14 Resonant Inc. USA Computers & Electronics 5/28/14 RESN $18.63 180 11/24/14 7 Deals $3,399.00 Issuer Totals Lock-up Exp. Date Bookrunner(s) Lead/CoManager(s) OPCO; PJ; STRH; COWEN CS; GS; JPM; WLF MS; RJA; TP; RBC; GLBGS; MGL; SBGBM; SCI; STEP MCU All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 22 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 Small Cap Equity Finance Activity SEC Registered IPOs Withdrawn/Postponed Since November 3, 2014 Nation Industry Withdrawn/ Postponed Date Ticker Expected Value ($M) Withdrawn/ Postponed Jaguar Animal Health Inc. USA Healthcare 11/5/14 JAGX $40.00 Radius Bancorp Inc. USA Finance 11/5/14 RADB PolyPid Ltd. ISR Healthcare 11/10/14 S1 Biopharma Inc. USA Healthcare 11/11/14 TransFirst Inc. USA Finance 11/12/14 DermTech International USA Healthcare 11/13/14 NW18 HSN Holdings plc IND Retail Issuer Totals Bookrunner(s) Lead/CoManager(s) Postponed Due to market conditions. BMOCM; GUGPAR RCP $63.75 Postponed BAIRD; SANDO JMS; WU PLPD $20.00 Postponed AEGC MLV; CHCML SXB $35.75 Postponed MLV NLND $100.00 Withdrawn BOAML; GS; JPM; DB EP; RJA; STRH; WLF; WBLR DMTK $15.00 Withdrawn MAXM FELL 11/13/14 HS $75.00 Withdrawn 7 Deals $349.50 Reason Due to market conditions. Due to acquisition by Vista Equity Partners. Due to market condition. CITI; CS SEC Registered Follow-Ons Filed Since November 3, 2014 Pricing Date Ticker Deal Value ($M) Last Trade b/f Filing Shares (M) Market Value ($M) Bookrunner(s) Real Estate/ Property 11/4/14 DCT $116.91 $8.66 15.53 $3,050.66 WLF USA Real Estate/ Property 11/4/14 HTA $103.76 $12.97 9.20 $3,202.90 JPM; WLF BAIRD; CAPONE; SANDO; SBGBM; STFL Northwestern Corp. USA Utility & Energy 11/4/14 NWE $400.00 $52.56 $2,375.23 CS; BOAML; JPM CIBC; KCM; MUFG; PJ; RBC; DD; LTC Umpqua Holdings Corp. USA Finance 11/4/14 UMPQ $548.96 $17.60 31.19 $3,823.78 BAR Macquarie Infrastructure Co. LLC USA Transportation 11/5/14 MIC $93.23 $71.88 1.30 $5,040.94 BAR Pioneer Natural Resources Co. USA Oil & Gas 11/5/14 PXD $1,040.23 $180.91 5.75 $26,937.12 CITI; BOAML Quintiles Transnational Holdings Inc. USA Healthcare 11/5/14 Q $529.65 $58.85 9.00 $7,270.83 CITI Southern First Bancshares Inc. USA Finance 11/5/14 SFST $17.28 $14.40 1.38 $91.20 SANDO Booz Allen Hamilton Holding Corp. USA Professional Services 11/6/14 BAH $263.10 $26.31 10.00 $3,888.76 JPM Mast Therapeutics Inc. USA Healthcare 11/6/14 MSTX $77.05 COWEN LDLW; MERRIM Western Digital Corp. USA Computers & Electronics 11/6/14 WDC $550.43 $101.28 $22,900.41 GS; BOAML; JPM; RBC NEEDHM; STFL; EP Orbcomm Inc. USA Telecommunications 11/7/14 ORBC $72.00 $6.23 $424.41 RJA; CG; MGL CHG; CHCML Plains GP Holdings LP USA Oil & Gas 11/10/14 PAGP $1,484.45 $26.99 63.25 $3,414.86 JPM; CITI; GS; BOAML; MS RJA; UBS; WLF AmSurg Corp. USA Healthcare 11/11/14 AMSG $233.76 $51.84 4.51 $1,651.62 GS Bloomin' Brands Inc. USA Dining & Lodging 11/11/14 BLMN $390.87 $21.35 18.31 $2,682.63 GS Issuer Nation Industry DCT Industrial Trust Inc. USA Healthcare Trust of America Inc. $0.48 6.25 Lead/CoManager(s) CONTINUED > All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 23 the DEALFLOW REPORT Tu e sday N ovember 18 2014 Small Cap Equity Finance Activity < Previous SEC Registered Follow-Ons Filed Since November 3, 2014 Issuer Nation Industry Pricing Date Ticker Deal Value ($M) Last Trade b/f Filing Shares (M) Market Value ($M) Bookrunner(s) Lead/CoManager(s) Brixmor Property Group Inc. USA Real Estate/ 11/11/14 Property BRX $606.75 $24.27 28.75 $7,086.25 BOAML; CITI; JPM; WLF; BAR; DB; RBC; UBS BAIRD; CAPONE; MUFG; PJ; PB; SANDO; STRH; BNYM; KCM; OPCO; TD; SBGBM Compass Diversified Holdings USA Professional 11/11/14 Services CODI $109.80 $18.30 6.90 $993.69 BOAML; MS; JEFF BCM; JU; JMS; RJA; WBLR Mid-Con Energy Partners LP USA Oil & Gas 11/11/14 MCEP $104.34 $17.99 6.67 $524.17 RBC; BOAML; RJA; UBS; WLF; BAIRD OPCO; CB; LTC; MLV; WU National Retail Properties Inc. USA Real Estate/ 11/11/14 Property NNN $155.72 $38.93 4.60 $5,106.69 BOAML; WLF; MS STFL; BCM; CAPONE; PB; STRH; PJ; BAIRD; FBR; LTC Platform Specialty Products Corp. USA Chemicals 11/11/14 PAH $368.37 $25.76 16.45 $4,496.32 CS; BAR; NOM; UBS BTIG; JU; MGL; WLF; CCG Sprouts Farmers Markets Inc. USA Retail 11/11/14 SFM $472.05 $31.47 17.25 $4,750.40 UBS Alamo Group Inc. USA Machinery 11/12/14 ALG $84.72 $49.19 1.98 $577.25 BOAML; EP; PJ Diamondback Energy Inc. USA Oil & Gas 11/12/14 FANG $135.00 $67.50 2.30 $3,822.53 CS Horizon Pharma plc USA Healthcare 11/13/14 HZNP $152.69 $13.10 11.66 $818.98 MS; CITI; COWEN; JEFF Premier Inc. USA Healthcare 11/13/14 PINC $116.96 $31.53 4.08 $1,199.54 JPM; BOAML; WLF Rexnord Corp. USA Machinery 11/13/14 RXN $401.37 $27.25 14.73 $2,771.05 CS Texas Capital Bancshares Inc. USA Finance 11/13/14 TCBI $155.78 $61.74 2.52 $2,822.33 JPM; DB Voya Financial Inc. USA Insurance 11/13/14 VOYA $1,200.90 $39.99 30.03 $9,849.54 BOAML; CITI Zoe's Kitchen Inc. USA Dining & Lodging 11/13/14 ZOES $133.76 $35.20 4.37 $624.73 JEFF; PJ; BAIRD WBLR; STEP; STFL EnLink Midstream Partners LP USA Utility & Energy 11/14/14 ENLK $309.02 $29.43 12.08 $7,167.38 WLF; BAR; BOAML; MS; CITI; CS; DB; GS; JEFF; JPM; UBS; RBC RJA; OPCO Autohome Inc. CHN Computers & Electronics ATHM $426.62 $50.19 9.78 $5,165.80 DB; GS Continental Building Products Inc. USA Construction/ Building CBPX $118.37 $16.91 8.05 $626.84 CITI; CS; RBC; BAR; DB Covenant Transportation Group Inc. USA Transportation CVTI $48.77 $22.17 2.53 $380.44 El Pollo Loco Holdings Inc. USA Dining & Lodging LOCO $219.54 $36.59 6.90 $1,351.96 JEFF; MS; BAIRD; WBLR STFL Energous Corp. USA Computers & Electronics WATT $23.00 $8.66 $82.19 OPCO RCP; NS Auto/Truck FCAU $408.45 $11.67 $14,437.89 JPM; GS; BAR; UBS GoPro Inc. USA Consumer Products GPRO $800.00 $79.06 $9,943.94 JPM; BAR; MS; CITI Moelis & Co. USA MC $137.40 $34.35 $1,765.33 GS; MOELISCO; MS Deals $12,534.01 FCA ITA Totals Finance 30 35.00 4.60 CITI; RJA; STRH; WBLR STEP; BCM VP; COWEN; WOLFE ALLENL; STFL; BAIRD; JMPSEC; PJ; RJA All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 24 the DEALFLOW REPORT Tu e sday N ovember 18 2014 Small Cap Equity Finance Activity SEC Registered Follow-Ons Priced Since November 3, 2014 Issuer Pricing Ticker Date Deal Value ($M) Offer Last Traded/ Price. Offer % Change Prem./ Price Offer/ Disc. % Current Bookrunner(s) Lead/ Co-Manager(s) Nation Industry Hilton Worldwide Holdings Inc. USA Dining & Lodging 11/3/14 HLT $2,587.50 $25.00 $25.25 -0.99 1.48 DB; GS; BOAML; MS; JPM; CITI; CS; WLF DCT Industrial Trust Inc. USA Real Estate/ Property 11/4/14 DCT $113.67 $8.42 $8.66 -2.77 -0.36 WLF Healthcare Trust of America Inc. USA Real Estate/ Property 11/4/14 HTA $100.40 $12.55 $12.97 -3.24 -0.96 JPM; WLF BAIRD; CAPONE; SANDO; SBGBM; STFL Northwestern Corp. USA Utility & Energy 11/4/14 NWE $400.00 $51.50 $51.74 -0.46 1.17 CS; BOAML; JPM CIBC; KCM; MUFG; PJ; RBC; DD; LTC Umpqua Holdings Corp. USA Finance 11/4/14 UMPQ $520.88 $16.70 $17.60 -5.11 5.63 BAR Macquarie Infrastructure Co. LLC USA Transportation 11/5/14 MIC $91.93 $70.88 $71.88 -1.39 -2.10 BAR Pioneer Natural Resources Co. USA Oil & Gas 11/5/14 PXD $1,006.25 $175.00 $180.91 -3.27 -5.62 CITI; BOAML Quintiles Transnational Holdings Inc. USA Healthcare 11/5/14 Q $523.80 $58.20 $58.85 -1.10 -3.11 CITI Southern First Bancshares Inc. USA Finance 11/5/14 SFST $19.87 $14.40 $15.11 -4.70 9.72 SANDO Booz Allen Hamilton Holding Corp. USA Professional Services 11/6/14 BAH $252.50 $25.25 $26.31 -4.03 5.15 JPM Mast Therapeutics Inc. USA Healthcare 11/6/14 MSTX $21.00 $0.48 $0.48 -0.66 -0.04 COWEN LDLW; MERRIM Western Digital Corp. USA Computers & Electronics 11/6/14 WDC $600.00 $96.00 $97.87 -1.91 1.91 GS; BOAML; JPM; RBC NEEDHM; STFL; EP Orbcomm Inc. USATelecommunications 11/7/14 ORBC $72.00 $5.60 $6.23 -10.11 15.54 RJA; CG; MGL CHG; CHCML Plains GP Holdings LP USA Oil & Gas 11/10/14 PAGP $1,725.00 $25.00 $25.10 -0.40 11.00 JPM; CITI; GS; BOAML; MS RJA; UBS; WLF AmSurg Corp. USA Healthcare 11/11/14 AMSG $228.17 $50.60 $51.84 -2.39 -0.67 GS Bloomin' Brands Inc. USA Dining & Lodging 11/11/14 BLMN $375.31 $20.50 $21.35 -3.98 6.83 GS Brixmor Property Group Inc. USA Real Estate/ Property 11/11/14 BRX $682.81 $23.75 $23.91 -0.67 0.00 BOAML; CITI; JPM; BAIRD; CAPONE; WLF; BAR; DB; RBC; MUFG; PJ; PB; UBS SANDO; STRH; BNYM; KCM; OPCO; TD; SBGBM Compass Diversified Holdings USA Professional Services 11/11/14 CODI $106.50 $17.75 $18.30 -3.01 -3.89 BOAML; MS; JEFF BCM; JU; JMS; RJA; WBLR Mid-Con Energy Partners LP USA Oil & Gas 11/11/14 MCEP $100.17 $17.27 $17.99 -4.00 -2.66 RBC; BOAML; RJA; OPCO; CB; LTC; MLV; UBS; WLF; BAIRD WU National Retail Properties Inc. USA Real Estate/ Property 11/11/14 NNN $208.45 $38.16 $38.93 -1.98 -0.50 BOAML; WLF; MS STFL; BCM; CAPONE; PB; STRH; PJ; BAIRD; FBR; LTC Platform Specialty Products Corp. USA Chemicals 11/11/14 PAH $350.35 $24.50 $25.01 -2.04 1.84 CS; BAR; NOM; UBS BTIG; JU; MGL; WLF; CCG Sprouts Farmers Markets Inc. USA Retail 11/11/14 SFM $444.00 $29.60 $31.47 -5.94 2.11 UBS Alamo Group Inc. USA Machinery 11/12/14 ALG $85.17 $43.00 $47.51 -9.49 4.16 BOAML; EP; PJ HSBC; UBS; BAR; CACIB; MGL; NOM; MUFG; RBS; BAIRD; EP; RBC; COK; RAMSAM; TELAG CONTINUED > All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 25 the DEALFLOW REPORT Tu e sday November 18 2014 Small Cap Equity Finance Activity < Previous SEC Registered Follow-Ons Priced Since November 3, 2014 Issuer Pricing Ticker Date Deal Value ($M) Offer Last Traded/ Price. Offer % Change Prem./ Price Offer/ Disc. % Current Industry Diamondback Energy Inc. USA Oil & Gas 11/12/14 FANG $130.20 $65.10 $67.50 -3.56 -0.52 CS Memorial Resource Development Corp. USA Oil & Gas 11/12/14 MRD $690.00 $23.00 $23.53 -2.25 -1.22 CITI; BAR; BOAML; BMOCM; GS; JPM; RJA; RBC; WLF CS; SBGBM; SCI; STEP; STFL; WU; CACIB; NATX TrueCar Inc. USA Computers & Electronics 11/12/14 TRUE $108.84 $17.00 $17.49 -2.80 -0.65 JPM; GS; MS; RBC JMPSEC; COWEN Horizon Pharma plc USA Healthcare 11/13/14 HZNP $140.51 $12.05 $12.39 -2.74 Newtek Business Services Corp. USA Finance 11/13/14 NEWT $27.50 $12.50 $12.65 -1.19 Premier Inc. USA Healthcare 11/13/14 PINC $120.00 $32.35 $32.35 0.00 Rexnord Corp. USA Machinery 11/13/14 RXN $394.00 $26.75 $27.25 -1.83 -0.97 CS Texas Capital Bancshares Inc. USA Finance 11/13/14 TCBI $151.89 $60.20 $61.74 -2.49 -1.48 JPM; DB Voya Financial Inc. USA Insurance 11/13/14 VOYA $1,180.18 $39.30 $39.99 -1.73 -0.10 Zoe's Kitchen Inc. USA Dining & Lodging 11/13/14 ZOES $121.60 $32.00 $32.42 -1.30 JEFF; PJ; BAIRD Cheniere Energy Partners LP Holdings LLC USA Utility & Energy 11/14/14 CQH $234.83 $23.25 $23.91 -2.76 CS EnLink Midstream Partners LP USA Utility & Energy 11/14/14 ENLK $297.89 $28.37 $29.43 -3.60 WLF; BAR; BOAML; MS; CITI; CS; DB; GS; JEFF; JPM; UBS; RBC 35 Deals $14,213.17 Totals Bookrunner(s) Lead/ Co-Manager(s) Nation MS; CITI; COWEN; JEFF 3.28 JMPSEC; LTC LCLLC JPM; BOAML; WLF CITI; RJA; STRH; WBLR BOAML; CITI WBLR; STEP; STFL RJA; OPCO SEC Registered Follow-Ons with Lock-up Expirations Within Next 2 Weeks Issuer Deal Value Lock-up Lock-up Exp. ($M) Prov. Date Nation Industry Pricing Date Ticker Bookrunner(s) Lead/Co-Manager(s) Legacy Reserves LP USA Oil & Gas 10/3/14 LGCY $314.87 45 11/17/14 UBS; BOAML; RBC; WLF; BAR; CITI; JPM; RJA BAIRD; LTC; MLV; JMS; WU Chatham Lodging Trust USA Real Estate/ Property 9/19/14 CLDT $150.77 60 11/18/14 BAR; BOAML; UBS BAIRD; CACIB; PJ; STFL; FBR; JMPSEC; STRH WaferGen Bio-Systems Inc. USA Professional Services 8/21/14 WGBS $20.00 90 11/19/14 LTC NS; BRNCAP ZBB Energy Corp. USA Utility & Energy 8/21/14 ZBB $14.84 90 11/19/14 CHG Natural Resource Partners LP USA Mining BreitBurn Energy Partners LP USA Oil & Gas 10/6/14 NRP $102.17 45 11/20/14 CITI; WLF; BOAML; UBS STFL; BCM 10/7/14 BBEP $260.96 45 11/21/14 BOAML; BAR; CITI; MS; RBC; UBS; WLF; CS; JPM BAIRD; JMS; MLV; OPCO; STFL; WU; GLBGS; JHWL; LTC Burlington Stores Inc. USA Retail 10/7/14 BURL $306.00 45 11/21/14 JPM Celator Pharmaceuticals Inc. USA Healthcare 10/22/14 CPXX $14.83 30 11/21/14 RCP; NS KCAP Financial Inc. USA Finance 10/7/14 KCAP $24.90 45 11/21/14 JMPSEC Parkway Properties Inc. USA Real Estate/ Property 9/22/14 PKY $213.90 60 11/21/14 BOAML; WLF; BAR; MS RBC; KCM; PJ; STFL; JMPSEC AVANIR Pharmaceuticals USA Healthcare 9/23/14 AVNR $230.23 60 11/22/14 JPM; DB; BOAML PJ; JMPSEC CONTINUED > All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 26 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 Small Cap Equity Finance Activity < Previous SEC Registered Follow-Ons with Lock-up Expirations Within Next 2 Weeks Issuer Deal Value Lock-up Lock-up Exp. ($M) Prov. Date Nation Industry Pricing Date Ticker Bookrunner(s) Lead/Co-Manager(s) Gladstone Land Corp. USA Real Estate/ Property 9/24/14 LAND $15.02 60 11/23/14 JMS; OPCO; JMPSEC LTC; MAXM; JHWL; SIDO Motorcar Parts of America Inc. USA Machinery 8/26/14 MPAA $71.76 90 11/24/14 CHG; RCP Pebblebrook Hotel Trust USA Real Estate/ Property 10/28/14 PEB $147.20 30 11/27/14 WLF Sabra Health Care REIT Inc. USA Real Estate/ Property 9/29/14 SBRA $167.33 60 11/28/14 BOAML; BAR; RBC; RJA Acadia Realty Trust USA Real Estate/ Property 10/30/14 AKR $116.32 30 11/29/14 BOAML; BAR CubeSmart USA Real Estate/ Property 10/15/14 CUBE $144.49 45 11/29/14 BAR; JEFF Corporate Office Properties Trust USA Real Estate/ Property 10/31/14 OFC $150.70 30 11/30/14 WLF Susser Petroleum Partners LP USA Oil & Gas 10/21/14 SUSP $370.00 40 11/30/14 MS; BOAML; BAR; CITI; CS; DB; GS; JEFF; JPM; RBC; UBS; WLF 19 Deals $2,836.29 Totals OPCO; JPM; STRH Registered Offerings and CMPOs Priced/Closed Since November 3, 2014 Issuer Nation Industry Status Date Type Deal Amt ($M) Sec. Ticker Type Mkt. Cap (M) Stock Price Prem/ Disc % WC(s) Placement Agents/ Underwriters AxoGen Corp. USA Healthcare Closed 11/13/14 RD $3.55 CS AXGN $44.54 $2.55 -1.90% N/A AxoGen Corp. USA Healthcare Closed 11/13/14 RD $1.75 CS AXGN $44.54 $2.55 6.70% N/A CTI BioPharma Corp. USA Healthcare Closed 11/13/14 CMPO $35.00 PSC CTIC $327.20 $2.18 -15.30% N/A PJ; RCP; LTC; JMS Mast Therapeutics Inc. USA Healthcare Closed 11/13/14 CMPO $14.85 CS MSTX $59.32 $0.46 -0.70% 50.00% COWEN; CG; LLGSE Mast Therapeutics Inc. USA Healthcare Closed 11/13/14 CMPO $6.15 PW MSTX $59.32 $0.46 -0.70% 50.00% COWEN; CG; LLGSE Orbcomm Inc. USA Telecommunications Closed 11/13/14 CMPO $82.80 CS ORBC $363.10 $6.57 -10.40% N/A RJA; CG; MGL; CHG; CHCML Lightbridge Corp. USA Energy Priced 11/12/14 RD $5.04 CS LTBR $35.27 $2.34 -25.20% 95.00% WBLR Southcross Energy Partners LP USA Energy Closed 11/12/14 RD $75.00 ATM SXE $451.83 $18.98 0.00% N/A WLF; JPM; RBC USA Compression Partners LP USA Industrial Closed 11/12/14 RD $150.00 ATM USAC $694.18 $22.60 0.00% N/A UBS; RJA; RBC; STRH Geo Group Inc. USA Real Estate Closed 11/10/14 RD $100.00 ATM GEO $3,007.21 $41.40 0.00% N/A STRH; WLF; JPM; VP; BOAML; BAR; MCNIC American Superconductor Corp. USA Technology Priced 11/7/14 RD $10.00 CS AMSC $117.65 $1.36 -19.10% 90.00% COWEN; MCNIC Cadiz Inc. USA Consumer/Retail Priced 11/7/14 RD $12.21 CS CDZI $158.81 $9.80 Clean Diesel Technologies Inc. USA Closed 11/7/14 RD $4.35 CS CDTI $33.64 $2.71 Industrial 3.80% N/A -11.70% 25.00% COWEN CONTINUED > All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 27 the DEALFLOW REPORT Tu e sday November 18 2014 Small Cap Equity Finance Activity < Previous Registered Offerings and CMPOs Priced/Closed Since November 3, 2014 Issuer Nation EnLink Midstream Partners LP Industry Status USA Energy Closed Date Type Deal Amt ($M) 11/7/14 RD $350.00 Sec. Ticker Type ATM ENLK Mkt. Cap (M) Stock Price Prem/ Disc % WC(s) $6,828.16 $29.30 0.00% N/A Placement Agents/ Underwriters BMOCM; BOAML; CITI; JEFF; RJA; RBC InspireMD Inc. USA Healthcare Closed 11/7/14 RD $8.14 CS NSPR $45.17 $1.25 Prospect Capital Corp. USA Financial Institutions Closed 11/7/14 RD Unknown ATM PSEC $3,293.26 $9.34 0.00% N/A KCM; CM; GS; RBC; BR Sunoco Logistics Partners LP USA Energy Closed 11/6/14 RD $1,000.00 ATM SXL $10,029.13 $45.45 0.00% N/A RBC; BOAML; BAR; BNP; CITI; CS; DB; GS; JEFF; JPM; MUFG; MS; SC; STRH; UBS; WFS Vanda Pharmaceuticals Inc. USA Healthcare Closed 11/3/14 CMPO $66.70 CS VNDA $407.15 $12.01 -3.60% N/A JEFF; PJ; JMPSEC; CG WidePoint Corp. USA Technology Closed 11/3/14 CMPO $11.50 CS WYY $114.60 $1.56 -9.90% N/A BRO; CHG 19 Deals $1,937.04 Totals -15.60% 50.00% HWC Shelf Registration Statements Filed Since November 3, 2014 Reg. Amt. ($M) Securities 11/14/14 $100.00 Equity/Debt 11/14/14 $30.00 Equity S-3 11/13/14 $100.00 Equity/Debt IIN S-3 11/13/14 $10.00 Equity/Debt BNS F-3 11/12/14 $7,000.00 Equity/Debt Blue Earth Inc. BBLU S-3 11/12/14 $50.00 Equity/Debt Cherry Hill Mortgage Investment Corp. CHMI S-3 11/12/14 $500.00 Equity/Debt MacroGenics Inc. Issuer Ticker Type Filing Date First NBC Bank Holding Co. NBCB S-3 Lantronix Inc. LTRX S-3 Evoke Pharma Inc. EVOK IntriCon Corp. Bank of Nova Scotia MGNX S-3 11/12/14 Premier Inc. PINC S-3ASR 11/12/14 Sprague Resources LP SRLP S-3 11/12/14 Walter Energy Inc. WLT S-3 11/12/14 Brixmor Property Group Inc. BRX S-3ASR 11/10/14 Dynavax Technologies Corp. DVAX S-3 Five Prime Therapeutics Inc. FPRX OvaScience Inc. SUPERVALU INC. Eff. Date $150.00 Equity/Debt Unlimited Equity/Debt $1,000.00 Equity/Debt 11/12/14 Unlimited Equity/Debt 11/10/14 Unlimited Equity/Debt 11/10/14 $200.00 Equity/Debt S-3 11/10/14 $100.00 Equity OVAS S-3 11/10/14 $150.00 Equity/Debt 11/12/14 SVU S-3ASR 11/10/14 11/10/14 Unlimited Debt Century Aluminum Co. CENX S-3ASR 11/7/14 11/7/14 Unlimited Equity/Debt Cymabay Therapeutics Inc. CBAY S-3 11/7/14 $100.00 Equity/Debt Education Realty Trust Inc. EDR S-3ASR 11/7/14 11/7/14 Unlimited Equity EA S-3ASR 11/7/14 11/7/14 Unlimited Equity/Debt Electronic Arts Inc. CONTINUED > All data is based on proproetary information from Dealogic. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. close print back < Index > cover search view 28 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 Small Cap Equity Finance Activity < Previous Shelf Registration Statements Filed Since November 3, 2014 Issuer Ticker Type Filing Date Endurance International Group Holdings Inc. EIGI S-3 11/7/14 JPMorgan Chase & Co. JPM S-3ASR 11/7/14 Niska Gas Storage Partners LLC NKA S-3 11/7/14 Pernix Therapeutics Holdings Inc. PTX S-3 11/7/14 Plum Creek Timber Co. PCL S-3ASR 11/7/14 PRMW S-3 Sagent Pharmaceuticals Inc. SGNT TransEnterix Inc. Reg. Amt. ($M) Securities $49.44 Equity Unlimited Debt $1,250.00 Equity/Debt Eff. Date 11/7/14 $300.00 Equity/Debt Unlimited Equity/Debt 11/7/14 $75.00 Equity/Debt S-3 11/7/14 $799.95 Equity/Debt TRXC S-3 11/7/14 $100.00 Equity/Debt Unum Group UNM S-3ASR 11/7/14 11/7/14 Unlimited Equity/Debt CBS Corp. CBS S-3ASR 11/6/14 11/6/14 Unlimited Equity/Debt PMFG Inc. PMFG S-3 11/6/14 $100.00 Equity/Debt Telus Corp. TU F-10 11/6/14 $3,000.00 Equity/Debt Zogenix Inc. ZGNX S-3 11/6/14 $100.00 Equity/Debt Ironwood Pharmaceuticals Inc. IRWD S-3ASR 11/5/14 Unlimited Equity/Debt LDR Holding Corp. LDRH S-3 11/5/14 $150.00 Equity/Debt Midway Gold Corp. MDW S-3 11/5/14 $50.00 Equity OCR S-3ASR 11/5/14 Unlimited Equity/Debt PACB S-3 11/5/14 $150.00 Equity/Debt Primo Water Corp. Omnicare Inc. Pacific Biosciences of California Inc. 11/7/14 11/5/14 11/5/14 Uroplasty UPIData is updated based on availability of S-3 11/5/14 $50.00 All data isInc. based on proproetary information from Dealogic. public disclosures (e.g. press releases and SEC filings) or has been obtained fromEquity sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee the accuracy and completeness of this information. Assurant Inc. MB Financial Inc. QTS Realty Trust Inc. Quintiles Transnational Holdings Inc. Sorrento Therapeutics Inc. XL Group plc AIZ S-3ASR 11/4/14 11/4/14 Unlimited Equity/Debt MBFI S-3ASR 11/4/14 11/4/14 Unlimited Equity/Debt QTS S-3 11/4/14 $1,000.00 Equity Unlimited Equity $250.00 Equity Q S-3ASR 11/4/14 SRNE S-3 11/4/14 11/4/14 XL S-3ASR 11/4/14 11/4/14 Unlimited Equity/Debt Aerie Pharmaceuticals Inc. AERI S-3 11/3/14 11/10/14 $150.00 Equity Las Vegas Sands Corp. LVS S-3ASR 11/3/14 11/3/14 Unlimited Equity/Debt PRAN F-3 11/3/14 11/10/14 $50.00 Equity 25 Shelf Registeration Statements Prana Biotechnology Ltd. Totals Shell Merger Activity Since November 3, 2014 Merger Date Surviving Company Ticker 11/10/14 Legacy Education Alliance Inc. 11/5/14 3D Makerjet Inc. Shell Company PRCD Private Company Recent Price Avg Vol 3 Mo Market Cap Shares Out ($M) (M) Priced In Corp. Legacy Education Alliance Holdings N/A N/A N/A 4.00 3D Makerjet Inc. (f/k/a American Business Change Agents Inc.) 3D MakerJet Asia Ltd. N/A N/A N/A 31.20 Related PIPE Financing(s) ($M) Includes companies which have completed mergers of private operating businesses into public shell companies as defined by the Securities and Exchange Commission. The information is derived from public filings with the Securities and Exchange Commission, Nasdaq and company announcements, sources which The Deal believes to be current and reliable. However, we cannot guarantee the accuracy and completeness of the information, which may be revised at any time. Total outstanding share amounts may reflect either pre- or post-merger ownership. N/T = Not Trading. close print back < Index > cover search view 29 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 Small Cap Equity Finance Activity Shell Companies Since November 3, 2014 Initial Filing Date Company Ticker State of Incorporation Date of Incorporation Sharings Outstanding Authorized Shares Number of (M) Shareholders 11/3/14 Deer Valley Acquisition Corp. Delaware 9/25/14 20 100 2 11/3/14 Elm Valley Acquisition Corp. Delaware 9/25/14 20 100 2 11/3/14 Fox Valley Acquisition Corp. Delaware 9/25/14 20 100 2 11/3/14 Oak Valley Acquisition Corp. Delaware 9/25/14 20 100 2 11/3/14 Owl Valley Acquisition Corp. Delaware 9/25/14 20 100 2 11/3/14 Redwood Valley Acquisition Corp. Delaware 9/25/14 20 100 2 11/3/14 Sirrus Corp. Nevada 3/7/14 25 200 1 11/3/14 Spruce Valley Acquisition Corp. Delaware 9/25/14 20 100 2 Includes SEC reporting companies which have declared their shell status and/or intent to merge with an operating company in a recent SEC filing; have non-financial assets of less than $100,000; have annual operating revenues of less than $100,000; have not been declared a delinquent filer by the SEC or their primary listing market; and have not already announced a completed reverse merger. We cannot guarantee the accuracy or completeness of the information, which may be revised at any time. N/T = Not Trading. SPAC IPOs in Registration S-1/F-1 Date Days in Registration 1/14/11 1,400 12/23/11 1,057 RNK Global Development Acquisition Corp. 1/13/12 1,036 Chardan Metropol Acquisition Corp. 4/25/12 933 Energy, infrastructure, telecommunications and consumerrelated sectors in Russia BSP Acquisition Corp. 5/19/14 179 Harmony Merger Corp. 7/9/14 128 SPAC China Resources Development Inc. Pacific Monument Acquisition Corp. Quinpario Acquisition Corp. 2 9/26/14 CB Pharma Acquisition Corp. 10/23/14 22 Arowana Inc. 10/24/14 Barington/Hilco Acquisition Corp. 11/13/14 Sector Focus IPO Amt IPO Trust ($M) ($M) Investment Banker(s) Legal Counsel Basic minerals mining Lazard Capital Markets; Ladenburg companies (and related busi- Thalmann & Co.; Chardan Capital nesses) located in or serving Markets; I-Bankers Securities Inc. China Graubard Miller; Conyers Dill & Pearman; Skadden, Arps, Slate, Meagher & Flom LLP; Wu & Kao, P.L.L.C. $50.00 $50.25 Morgan Joseph TriArtisan LLC; Graubard Miller; Ellenoff Grossman Ladenburg Thalmann & Co. and Schole LLP $40.00 $40.60 Security and defense sector Chardan Capital Markets Golenbock Eiseman Assor Bell & Peskoe, LLP; Conyers Dill & Pearman; Loeb & Loeb LLP $40.00 $40.15 Chardan Capital Markets Conyers Dill & Pearman; Loeb & Loeb LLP $40.00 $40.00 Cantor Fitzgerald & Co. Ellenoff Grossman and Schole LLP; Graubard Miller $100.00 $100.00 Cantor Fitzgerald & Co. Graubard Miller; Ellenoff Grossman and Schole LLP $100.00 $100.00 Transportation, travel and leisure industries 49 Specialty chemicals and performance materials industries Deutsche Bank Securities Inc.; Cantor Fitzgerald & Co. Graubard Miller; Kirkland & Ellis LLP $350.00 $350.00 Specialty pharma and generic drug companies in North America, Europe, South America and Asia EarlyBirdCapital Inc. Graubard Miller; Maples and Calder (PRC); McDermott Will & Emery LLP $40.00 $40.20 21 Energy or education companies operating or seeking to expand in the Asia Pacific region EarlyBirdCapital Inc. Graubard Miller; Maples and Calder (PRC); McDermott Will & Emery LLP $60.00 $60.30 1 Consumer-focused businesses located in the U.S. EarlyBirdCapital Inc. Kramer Levin Naftalis & Frankel LLP; Graubard Miller $40.00 $40.80 Includes “special purpose acquisition companies” which have completed IPOs as blank check companies exempt from Rule 419 of the Securities Act of 1933 and the Penny Stock Reform Act of 1990, and are listed on the Over-the-Counter Bulletin Board, the Nasdaq Stock Market, or a primary U.S. exchange and have not completed acquisitions. The information is derived from public filings with the Securities and Exchange Commission, Nasdaq and company announcements, sources which The Deal believes to be current and reliable. However, we cannot guarantee the accuracy and completeness of the information, which may be revised at any time. Some trust amounts may include proceeds from concurrent private placements. close print back < Index > cover search view 30 the DEALFLOW REPORT Tu e sday N ovembe r 18 2014 Small Cap Equity Finance Activity Trading SPACs SPAC Tickers IPO Date Bankers AR Capital Acquisition AUMAU 10/7/14 Corp. Citigroup Global Markets Inc.; Ladenburg Thalmann & Co. DT Asia Investments Ltd. CADTU 10/6/14 Sino Mercury Acquisi- SMACU tion Corp. EarlyBirdCapital Inc.; Aegis Capital Corp.; I-Bankers Securities Inc. Sector Focus/ Recent Avg Vol Market Cap Startegy Price (3 mos) ($M) Asset management industry $9.78 210,723 IPO Amt IPO Trust ($M) ($M) $366.75 $ 240.00 $240.00 65,181 $78.20 $ 60.00 $69.97 $9.99 471 $54.13 $ 40.00 $40.80 Company with an enterprise value $10.01 of between $200 million and $1.25 billion 36,862 $232.17 $ 185.00 $212.75 Companies having a total enterprise $10.00 value in excess of $300 million with operations in China or Asia 9/2/14 Cantor Fitzgerald & Co. TRTLU 7/22/14 Deutsche Bank AG 1347 Capital Corp. TFSC 7/21/14 EarlyBirdCapital Inc.; Aegis Capital Corp. Businesses operating in or providing services to the insurance industry $9.54 14,620 $56.86 $ 40.00 $46.00 Garnero Group Acquisition Co. GGAC 7/1/14 EarlyBirdCapital Inc.; I-Bankers Securities Inc.; Ladenburg Thalmann & Co.; Aegis Capital Corp. Energy or biotechnology companies operating in Latin America or Europe $9.65 22,980 $179.51 $ 125.00 $144.47 WL Ross Holding Corp. WLRH 6/11/14 Deutsche Bank AG; Bank of America Corp. Distressed or underperforming $10.00 companies in industries undergoing periods of dislocation 87,490 $625.31 $ 435.00 $500.25 Committed Capital Acquisition Corp. II CCAQ 4/16/14 Broadband Capital Management LLC Operating business in the U.S. having a fair market value between $100 million and $300 million $4.90 300 $177.43 $ 35.00 $40.00 Boulevard Acquisition Corp. BLVD 2/19/14 Citigroup Global Markets Inc.; I-Bankers Securities Inc.; Maxim Group LLC Companies undergoing a transition as a result of a restructuring, change of business model or basis of competition $9.64 35,870 $265.71 $ 210.00 $220.50 Hennessy Capital Acquisition Corp. HCAC 1/23/14 Deutsche Bank Securities Inc. Operating business in the industrial manufacturing and distribution sectors $9.83 23,820 $141.31 $ 100.00 $115.00 Terrapin 3 Acquisition Corp. Business in China operating in the non-traditional financial industry (microcredit, financial leasing, guarantors) Target(s) WISeKey SA; WISeKey USA Inc. School Bus Holdings Inc.; Blue Bird Corp. CONTINUED > Includes “special purpose acquisition companies” which have completed IPOs as blank check companies exempt from Rule 419 of the Securities Act of 1933 and the Penny Stock Reform Act of 1990, and are listed on the Over-the-Counter Bulletin Board, the Nasdaq Stock Market, or a primary U.S. exchange and have not completed acquisitions. The information is derived from public filings with the Securities and Exchange Commission, Nasdaq and company announcements, sources which The Deal believes to be current and reliable. However, we cannot guarantee the accuracy and completeness of the information, which may be revised at any time. Some trust amounts may include proceeds from concurrent private placements. close print back < Index > cover search view 31 the DEALFLOW REPORT Tu e sday November 18 2014 Small Cap Equity Finance Activity < Previous Trading SPACs Sector Focus/ Startegy Recent Avg Vol Market Cap Price (3 mos) ($M) SPAC Tickers IPO Date Bankers Cambridge Capital Acquisition Corp. CAMBU 12/23/13 EarlyBirdCapital Inc.; Sidoti & Co. LLC; I-Bankers Securities Inc.; Aegis Capital Corp. Businesses operating in the supply $10.10 chain industry, specifically in the traditional transportation and logistics end of the industry Levy Acquisition Corp. LEVY 11/19/13 Citigroup Global Markets Inc.; I-Bankers Securities Inc.; Maxim Group LLC; National Securities Corp. Restaurant and hospitality sectors Global Defense & National Security Systems Inc. GDEF 10/29/13 Cowen and Co.; Maxim Group LLC; I-Bankers Securities Inc. Defense and national security sec- $10.30 tors in the U.S. ROI Acquisition Corp. II ROIQ 9/20/13 Deutsche Bank Securities Inc. Consumer sector (consumer products, retail or restaurant industry) or financial services sector (asset management industry) in the U.S. or globally Silver Eagle Acquisition Corp. EAGL 7/30/13 Deutsche Bank Securities Inc. 7/2/13 EarlyBirdCapital Inc.; Aegis Capital Corp. Capitol Acquisition Corp. II CLAC 5/15/13 HF2 Financial Management Inc. IPO Amt IPO Trust ($M) ($M) Target(s) 2,234 $95.63 $ 70.00 $81.31 $9.72 100,650 $182.25 $ 150.00 $150.00 31,690 $99.14 $ 60.00 $72.80 $9.65 42,850 $150.78 $ 125.00 $125.00 Media and entertainment business, including providers of content in the U.S. and internationally $9.79 31,870 $397.72 $ 300.00 $325.00 Healthcare industry, with special focus on specialty pharmacy, infusion pharmacy and/or drug distribution sectors in the U.S. $8.30 2,750 $84.67 $ 52.80 $63.45 Citigroup Global Markets Inc.; Deutsche Bank Securities Inc.; Ladenburg Thalmann & Co.; Imperial Capital LLC $9.79 1,850 $244.75 $ 180.00 $200.00 HTWO 3/27/13 EarlyBirdCapital Inc.; Sandler O'Neill & Partners LP Companies operating in the financial $10.29 services industry 30,060 $242.76 $ 153.00 $184.75 ZAIS Group Parent LLC; ZAIS Group LLC Chart Acquisition Corp. CACG 12/19/12 Cowen and Co.; Mitsubishi UFJ Securities; Deutsche Bank Securities Inc. $9.70 18,860 $94.58 $ 75.00 $75.00 Tempus Intermediate Holdings LLC Collabrium Japan Acquisition Corp. JACQ 10/24/12 The PrinceRidge Group LLC Businesses with operations in Japan $11.00 or that are Japanese owned 130 $42.12 $ 40.00 $43.37 MergeWorthRx Corp. MWRX Provision and/or outsourcing of government services AeroCare Holdings Inc. Includes “special purpose acquisition companies” which have completed IPOs as blank check companies exempt from Rule 419 of the Securities Act of 1933 and the Penny Stock Reform Act of 1990, and are listed on the Over-the-Counter Bulletin Board, the Nasdaq Stock Market, or a primary U.S. exchange and have not completed acquisitions. The information is derived from public filings with the Securities and Exchange Commission, Nasdaq and company announcements, sources which The Deal believes to be current and reliable. However, we cannot guarantee the accuracy and completeness of the information, which may be revised at any time. Some trust amounts may include proceeds from concurrent private placements. close print back < Index > cover search view 32 the DEALFLOW REPORT Tu e sday N ovember 18 2014 Small Cap Equity Finance Activity Venture Capital Deals Since November 3, 2014 Date Company 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/14/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/13/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 Apio Systems Arkin Net Body Labs Clone Fingi Full Spectrum Laser Indice Semiconductor Infocyte Metal Networks Monteris Medical Quandl Rival IQ Validately Vida Wannabiz 7AC Technologies Blue Triangle BuzzMyVideos Carmell Therapeutics Chariot Cozymeal Curiosity D-Wave Systems Entomo Flowonix Medical Hibernum Créations ioSemantics know’N’act LEAGUE LensAR Lover.ly Qollaboration Razberi Scopely Speakaboos The Orange Chef VISANOW Wildcard ApplePie Capital BrightRoll CareLuLu Course Hero Degreed Echo360 Encycle Therapeutics Estimize Full Circle CRM gogobot Ineda Systems Round Funding Amount Series A Undisclosed Seed Seed Seed Undisclosed Undisclosed Seed Series A Series B Undisclosed Undisclosed Seed Seed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Seed Seed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Seed Undisclosed Series A Seed Series A Undisclosed Series B Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Series A Undisclosed Series C Undisclosed Undisclosed Series A Series C Series B $5,000,000 $7,000,000 $2,200,000 $75,000 $250,000 $10,000,000 $6,000,000 $500,000 $5,000,000 $30,000,000 $5,400,000 $1,000,000 $280,000 $1,300,000 $2,200,000 $1,250,000 Undisclosed $2,500,000 $303,818 $187,500 $175,000 $6,000,000 $2,193,685 $2,000,000 $40,000,000 $5,000,000 $2,380,000 $500,000 $4,000,000 $2,000,000 Undisclosed $210,000 $3,500,000 $35,800,000 $6,500,000 $935,000 $16,100,000 $10,000,000 $3,770,000 $640,000,000 $1,700,000 $15,000,000 $6,880,827 $18,000,000 $2,500,000 $350,000 $3,800,000 $20,000,000 Undisclosed Date Company 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/12/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/11/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/10/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 La Lumiere Mobiquity Modernizing Medicine Sentrian VersionOne VetDC Advice Interactive Avalara Cavendish Kinetics Elevate Digital Entryless EverNote Evident.io Farmers Edge FourKites Good Done Great Kinsa Mesh Networks Prostate Management Diagnostics Raise RepairPal Revel Systems Sunshine WeDidIt Xtime Ziarco Abeona Therapeutics Ambiq Micro DogVacay Highspot LiquidText Mindjet Niwa Prositions Restoration Robotics SolarBridge Technologies Spirometrix Vibrant YourCause Zerve Appifier BluWrap Cloud9 Analytics Cognitive Code Coherus BioSciences Confluent Encoding.com Gemr H2O Round Funding Amount Series B Undisclosed Undisclosed Series A Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Series B Seed Undisclosed Series A Undisclosed Seed Undisclosed Seed Undisclosed Series A Undisclosed Undisclosed Series C Seed Seed Undisclosed Series B Undisclosed Series C Series B Series A Seed Undisclosed Seed Undisclosed Undisclosed Undisclosed Series B Undisclosed Series A Undisclosed Undisclosed Undisclosed Series B Undisclosed Undisclosed Undisclosed Series B Series A Undisclosed $20,000,000 $3,000,000 $15,000,000 $12,000,000 $20,000,000 $587,313 Undisclosed $100,000,000 $7,000,000 $4,000,000 $225,000 $20,000,000 $9,850,000 Undisclosed $750,000 $500,000 Undisclosed $4,300,000 $1,600,000 $18,100,000 Undisclosed $1,000,000,000 $1,350,000 $660,000 $325,000,000 $33,100,000 $3,612,500 $15,000,000 $25,000,000 $9,600,000 $202,500 $10,000,000 Undisclosed $2,000,000 $45,208,699 Undisclosed $8,600,000 $750,000 $4,000,000 $20,000,000 Undisclosed $12,600,000 Undisclosed Undisclosed $85,050,000 $6,900,000 $3,500,000 $4,930,000 $8,900,000 CONTINUED > All data is based on proprietary information from PrivateRaise, a service of The Deal. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee te accuracy and completeness of this information. close print back < Index > cover search view 33 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 Small Cap Equity Finance Activity < Previous Venture Capital Deals Since November 3, 2014 Date Company 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/7/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/6/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 LawnStarter LeadFerret LumaStream Neuro Kinetics nVoq Parenthoods PBworks StratusLIVE Vivino C3Nano Chime Convercent Dashbox DecisionDesk Eos Energy Storage EverSpin Technologies Everyday Carry LogoGarden.com MediaRadar MeowChat Nevro OrthAlign PBworks Prepared Response Sandboxx Shippable Vicarious Watchup Ximedica Zen99 ZergNet Airspan Networks AnDAPT Blueshift Labs Braigo Labs Creditera Eaze Echo Labs Eyefluence FilmTrack Fuel3D MOGL NetSpeed Systems NotaryCam Ossia Paracosm Pendo Reno Sub-Systems Riffsy Round Funding Amount Undisclosed Seed Undisclosed Undisclosed Undisclosed Seed Undisclosed Undisclosed Undisclosed Series C Seed Undisclosed Undisclosed Seed Undisclosed Series B Seed Seed Undisclosed Series B Undisclosed Undisclosed Undisclosed Undisclosed Seed Series A Undisclosed Undisclosed Undisclosed Undisclosed Series A Series E Undisclosed Seed Undisclosed Series A Undisclosed Seed Undisclosed Series B Undisclosed Undisclosed Series B Seed Undisclosed Seed Seed Undisclosed Seed $720,000 $250,000 $412,697 $212,241 $456,000 $1,320,000 $355,000 $3,000,000 $12,218,729 $12,000,000 $8,000,000 $1,000,000 Undisclosed $1,500,000 $3,940,000 $7,015,729 $150,000 $750,000 $6,700,000 $8,000,000 $126,000,000 $15,000,000 $1,814,369 $406,360 $700,000 $8,000,000 $11,999,953 $2,750,000 Undisclosed $2,500,000 $3,200,000 $5,000,000 Undisclosed $2,600,000 Undisclosed $6,500,000 $1,500,000 $360,000 Undisclosed $10,000,000 $6,400,000 $11,000,000 Undisclosed $430,000 Undisclosed $3,300,000 $1,250,000 Undisclosed $3,500,000 Date Company 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/5/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/4/14 11/3/14 11/3/14 11/3/14 11/3/14 11/3/14 11/3/14 11/3/14 11/3/14 11/3/14 Senova Systems Stratoscale Thanx Tolero Pharmaceuticals VivaReal Wanderu WorkingPoint Xenon Pharmaceuticals Zift Solutions Audyssey Laboratories Avegant Better ATM Services Butterfly Network CA7CH Campus Quad Changelane Chargesafe Contactually Corona Labs CyVek DeltaDNA DigitalTangible eDivv Evermind Gigya Gravitant Imago BioSciences Imbue Incoming Media Inrix Iontera Kash LifeNexus Namely Nitro PrecisionHawk Prelert Rock Health Shareholder InSite bswift Classkick Fuze Network MX Rover.com Sociable Labs SomaLogic StyleHaul Tout Total: Round Series C Series B Series A Series B Undisclosed Series A Undisclosed Undisclosed Undisclosed Undisclosed Series A Undisclosed Undisclosed Series A Undisclosed Seed Seed Seed Undisclosed Undisclosed Undisclosed Seed Seed Undisclosed Undisclosed Series B Series A Seed Undisclosed Undisclosed Undisclosed Seed Undisclosed Series B Series B Series B Undisclosed Undisclosed Undisclosed Undisclosed Seed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed Undisclosed 195 Funding Amount $1,489,888 $32,000,000 $4,700,000 $8,000,000 $41,300,018 $5,600,000 Undisclosed $36,000,000 $920,406 Undisclosed $9,370,000 $945,200 $100,000,000 $450,000 $1,175,000 $200,000 $175,000 $2,000,000 Undisclosed $95,000,000 $3,000,000 $225,000 $75,000 $778,730 Undisclosed $25,000,000 $26,500,000 $175,000 Undisclosed Undisclosed $1,597,538 $2,000,000 $1,500,000 $12,000,000 $15,000,000 Undisclosed Undisclosed Undisclosed Undisclosed $400,000,000 $150,000 Undisclosed Undisclosed Undisclosed $5,375,499 $16,490,873 Undisclosed $3,147,362 All data is based on proprietary information from PrivateRaise, a service of The Deal. Data is updated based on availability of public disclosures (e.g. press releases and SEC filings) or has been obtained from sources deemed reliable, including certain third party sources. However, The Deal cannot guarantee te accuracy and completeness of this information. close print back < Index > cover search view 34 the DEALFLOW REPORT Tu e sday Novembe r 18 2014 COMPANY INDEX GTx Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Peak Resorts Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11, 14 Guggenheim Partners LLC . . . . . . . . . . . . . . . . . . . . . . 6 Piper Jaffray & Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 AerCap Holdings NV . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Guggenheim Securities LLC . . . . . . . . . . . . . . . . . . 6, 14 Powdr Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Air France SA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Habit Restaurants Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . 14 PricewaterhouseCoopers LLP . . . . . . . . . . . . . . . . . . . 6 Air Namibia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Herrick, Feinstein LLP . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Prides Capital Partners LLC . . . . . . . . . . . . . . . . . . . . . . 7 Airbus SAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 IntraLinks Holdings Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 6 Providence Service Corp. . . . . . . . . . . . . . . . . . . . . . . . 10 Aite Group LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Intrawest Resorts Holdings Inc. . . . . . . . . . . . . . . . . 12 Pyramid Peaks Foundation . . . . . . . . . . . . . . . . . . . . . . 9 Alberta Investment Management Corp. . . . . . . . . . 6 Intrepid Aviation Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Raymond James & Associates Inc. . . . . 10, 11, 12, 14 Alitalia SpA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 IssuWorks Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 RBC Capital Markets . . . . . . . . . . . . . . . . . . . . . 10, 11, 12 AlixPartners LLP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Jefferies LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Regado Biosciences Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 9 American Express Co. . . . . . . . . . . . . . . . . . . . . . . . . . . 10 JPMorgan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11, 14 Reservoir Capital Group LLC . . . . . . . . . . . . . . . . . . . . 11 American International Group Inc. . . . . . . . . . . . . . 11 JPMorgan Securities LLC . . . . . . . . . . . . . . . . . . . . . . . . 8 Revel Systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 American Skiing Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Kabbage Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Rich Dad Operating Co. LLC . . . . . . . . . . . . . . . . . . . . . 7 Avolon Holdings Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Keefe Bruyette & Woods Inc. . . . . . . . . . . . . . . . . . . . 14 Richards, Layton & Finger PA . . . . . . . . . . . . . . . . . . . . 6 Bank of America Merrill Lynch . . . . . . . . . . . . . . . 11, 14 KFT Trust . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Robert W. Baird & Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Bank of New York Mellon Trust Co. NA . . . . . . . . . . .8 Khosla Ventures III LP . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Roth Capital Partners LLC . . . . . . . . . . . . . . . . . . . . . . 14 BlackRock Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 King & Spalding LLP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 SAP Ventures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Blood Centers of America Inc. . . . . . . . . . . . . . . . . . . . 8 KiOR Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Savvis Communications Corp. . . . . . . . . . . . . . . . . . . . 8 BNP Paribas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Latham & Watkins LLP . . . . . . . . . . . . . . . . . . . 10, 11, 12 Scotiabank . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Boeing Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Lazard . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Second Sight Medical Products Inc. . . . . . . . . . . . . 14 Brown Rudnick LLP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Legacy Education Alliance Inc. . . . . . . . . . . . . . . . . . . 7 Skadden, Arps, Slate, Meagher & Flom LLP . . . . . . 8 BVF Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Leidos Engineering LLC . . . . . . . . . . . . . . . . . . . . . . . . . 6 Skymark Airlines Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Canaccord Genuity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 LendingClub Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 SoftBank Capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Centerbridge Partners LP . . . . . . . . . . . . . . . . . . . . . . 11 Lowenstein Sandler LLP . . . . . . . . . . . . . . . . . . . . . . . . . 5 A-l Cisco Systems Capital Corp. . . . . . . . . . . . . . . . . . . . . . 8 Contour Venture Partners . . . . . . . . . . . . . . . . . . . . . . 10 Cowen & Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Southern Ionics Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Starlight Capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Stephens Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 m-Z Stifel, Nicolaus & Co. . . . . . . . . . . . . . . . . . . . . . . . . . 11, 14 Credit Agricole CIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Mammoth Resorts LLC . . . . . . . . . . . . . . . . . . . . . . . . . 12 SunTrust Robinson Humphreys . . . . . . . . . . . . . 10, 12 Credit Suisse Securities (USA) LLC . . . . . . . . . . . . . . 14 Marsh & McLennan Cos. . . . . . . . . . . . . . . . . . . . . . . . . 10 Tiger Global Management LLC . . . . . . . . . . . . . . . . . 10 Crowell & Moring LLP . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Matrix Medical Network . . . . . . . . . . . . . . . . . . . . . . . . 10 Tigrent Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Davis Polk & Wardwell LLP . . . . . . . . . . . . . . . . . . . . . 11 MDB Capital Group LLC . . . . . . . . . . . . . . . . . . . . . . . . 14 TransFirst Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Deerfield Management Co. LP . . . . . . . . . . . . . . . . . . 8 Merrill Lynch, Pierce, Fenner & Smith Inc. . . . . . . . . 8 Trinity Partners LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8 Dendreon Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Milestone Aviation Group . . . . . . . . . . . . . . . . . . . . . . 11 UBS AG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10, 12 Deutsche Bank . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Mitsubishi UFJ Securities (USA) Inc. . . . . . . . . . . . . . 14 UBS Securities LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Deutsche Bank Securities Inc. . . . . . . . . . . . . . . . . . . 11 Morgan Stanley . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 USA Compression Partners LP . . . . . . . . . . . . . . . 10, 12 DGSE Companies Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Morgan Stanley & Co. LLC . . . . . . . . . . . . . . . . . . . . . . 14 Vail Resorts Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 EHi Car Services Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Needham & Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Vanguard Group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Ellenoff Grossman & Schole LLP . . . . . . . . . . . . . . . . 13 Needham & Co. LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Vertical Research Partners . . . . . . . . . . . . . . . . . . . . . . 14 EPR Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Neff Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Vinson & Elkins LLP . . . . . . . . . . . . . . . . . . . . . . . . . . 10, 12 Eureeca Capital SPC . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Neothetics Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Vista Equity Partners . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 FBR Capital Markets & Co. . . . . . . . . . . . . . . . . . . . . . . 14 New World Merchant Partners LLC . . . . . . . . . . . . . . 7 VNK Management LLC . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Fortress Investment Group LLC . . . . . . . . . . . . . . . . 12 Noble Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Vogel Farina LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Gates Ventures LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Oliver Wyman Group . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Wells Fargo Securities LLC . . . . . . . . . . . . . . . . . . . 11, 14 General Electric Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 On Deck Capital Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Welsh Carson Anderson & Stowe LP . . . . . . . . . . . . . 9 Goldman Sachs (Asia) LLC . . . . . . . . . . . . . . . . . . . . . . 14 Orrick, Herrington & Sutcliffe LLP . . . . . . . . . . . . . . 11 Willkie Farr & Gallagher LLP . . . . . . . . . . . . . . . . . . . . . 8 Goldman, Sachs & Co. . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Pasadena Investments LLC . . . . . . . . . . . . . . . . . . . . . . 1 Wilmer Cutler Pickering Hale and Dorr LLP . . . . . . 6 Google Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Paycom Software Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Wilson Sonsini Goodrich & Rosati PC . . . . . . . . . . . 11 Groupon Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 PayPal Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Zeno Consulting Group LLC . . . . . . . . . . . . . . . . . . . . . 4 close print back < Index > cover search view